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ABSTRACT
The resistance and immunologic responses of a Beg 
susceptible (C57BL/6) and Beg resistant (C3H/He) strain of 
mouse were compared after infection with Mycobacterium 
paratuberculosis. Bacterial resistance was evaluated by 
bacterial counts and histopathology of chronically infected 
mice. Levels of non-specific macrophage activation and the 
response of various T cell subsets were also evaluated 
following infection.
Susceptible mice orally infected with Mycobacterium 
paratuberculosis developed granulomatous lesions containing 
acid-fast bacteria in the mesenteric lymph nodes.
Significant differences in CFU of M. paratuberculosis 
were observed between C57BL/6 and C3H/He mice following an 
i.p. infection. Susceptible mice failed to limit bacterial 
proliferation, while bacterial counts progressively 
declined in resistant mice. Susceptible mice had numerous 
granulomas in the liver and developed mesenteric lymph node 
lesions. Resistant mice had fewer hepatic granulomas and 
did not develop mesenteric lymph nodes lesions.
Both strains of mice developed similar levels of non­
specific macrophage activation 10 days after i.p. infection 
with M. paratuberculosis as determined by a listeria 
challenge assay.
Differences were detected in the proportions of T 
cell subsets and activation markers between the two
ix
strains. Both control and infected C3H/He mice had higher 
percentages of CD4+ cells, whereas C57BL/6 mice had higher 
proportions of CD8+ and 7 S cells. Both strains responded 
to the initial infection with increased numbers of CD8+ 
and/or 7 S cells, but resistant mice responded with higher 
proportions of CD4+ cells, whereas C57BL/6 mice responded 
with higher percentages of 7 S T and/or CD8+ cells.
Differences in the expression of CD25+ and CD44+ 
cells were also detected between the two strains of mice. 
Expression of CD25 increased in resistant mice, but 
decreased in susceptible mice after infection. Overall 
CD44 expression was higher in susceptible mice but 
increased after infection in both mice.
These data suggest that resistance to M. 
paratuberculosis is associated with higher proportions of 
CD4+ T cells, while CD8+ and/or 7 $ T cells are associated 
with susceptibility. The decrease in CD25 receptor 
expression in susceptible mice suggests that a 
dysregulation in IL-2 or its receptor may also be involved 
in the pathogenesis of paratuberculosis.
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CHAPTER 1. INTRODUCTION, LITERATURE REVIEW, AND OBJECTIVES
The Disease in Ruminants
Introduction
Paratuberculosis (Johne's disease) is a chronic, 
granulomatous, intestinal disease of domestic and wild 
ruminants caused by the acid-fast bacterium Mvcobacterium 
paratuberculosis (1.1,1.2). The disease is characterized 
by progressive emaciation in all species affected, and in 
cattle by chronic, intermittent diarrhea (1.3). The 
infection is usually limited to the intestinal tract and 
mesenteric lymph nodes. Rarely, infections may disseminate 
via the bloodstream resulting in lesions in the liver, 
spleen, lung, kidneys, udders, genital organs, uterus, and 
fetal tissues (1.4-10). This disease has a worldwide 
distribution and causes major economic losses in the 
cattle, sheep, and goat industries (1 .1 ,1 .2 ).
Historical Overview
Paratuberculosis has probably been responsible for 
considerable cattle losses in parts of Europe for over 200 
years (1.2). The earliest mention of possible cases of 
paratuberculosis may be from d'Aroval, who in 1826 reported 
a form of enteritis which occurred in some cattle with 
chronic diarrhea (1.2). The characteristic thickening and 
corrugation of the intestinal mucosa in cattle dying from 
this disease was first described in 1881 by Hansen and 
Nielsen (1.2). The disease was further described in 1895
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by Johne and Frothingham who first demonstrated the 
presence of acid-fast bacilli in the intestinal tissues of 
diseased cattle (1.11). The presence of these bacilli led 
them to believe that the disease was an unusual form of 
tuberculosis. In 1906 the disease was reclassified by Bang 
as being distinct from tuberculosis and he coined the 
phrases "pseudo-tuberculosis enteritis" and "Johne's 
disease" to describe the condition (1.12). The disease was 
first reported in the United States in 1908 (1.13). The 
organism was first isolated and cultured in vitro in 1910 
by Twort who named the organism Mycobacterium enteriditis 
chronicae pseudotuberculosae bovis iohnei (1.14). The name 
was later unofficially shortened to Mycobacterium iohnei in 
several publications. Eventually the disease became known 
as paratuberculosis or Johne's disease and the name of the 
causative organism was officially changed to Mycobacterium 
paratuberculosis (1.2,1.15).
Clinical Features
Although animals become infected at an early age, 
signs of the disease usually do not occur until the animal 
is two to five years of age. Due to the slowly progressive 
nature of the disease, infected cattle may not display 
clinical signs of the disease for years after infection.
By the time the first case in a herd is diagnosed, 38-42% 
of the herd may be infected (1.16). The incubation period 
may range from less than 6 months to over 15 years (1.17)
3but the majority of cases occur between 3-5 years of age
(1.2). The youngest reported case was in a 4-month-old 
calf (1.18) and the oldest reported case occurred in a 15- 
year-old cow (1.17). The first clinical sign of a 
chronically infected cow is a non-responsive, chronic, 
intermittent diarrhea. Temporary periods of remission, 
lasting weeks to months, may occur. The diarrhea may 
subside during pregnancy, but will often return with 
greater severity following parturition (1 .2 ).
Clinical pathology values are either within normal 
limits or non-specific. The most common abnormalities are 
hypoproteinemia and anemia (1.19). Hypoproteinemia occurs 
due to a combination of protein loss and malabsorption 
(1.19). Anemia of chronic disease may occur (1.19).
Despite a normal appetite, infected animals eventually 
have significant weight loss, unthriftiness, dry skin, and 
a rough, shaggy hair coat (1.2). Emaciation and death 
usually occur within 6 months from the onset of clinical 
signs but the course of the disease may persist for several 
years. The disease may progress more rapidly in sheep and 
goats (1 .2 ).
Although the diagnosis of paratuberculosis in an 
animal with the typical clinical signs of the disease may 
be uncomplicated, the recognition of subclinical infections 
and inapparent carriers is more difficult. An infected 
herd may lack clinically apparent cases, yet there may be
4significant decreases in weight gains, decreased milk 
production and quality, high rates of infertility, and 
increased susceptibility to mastitis and other concurrent 
infections (1 .2 ,1 .2 0 ,1 .2 1 ).
Although controversial, there is a possibility that 
certain breeds are predisposed to paratuberculosis. Field 
observations indicate a much higher prevalence in the 
Channel Island and Shorthorn breeds of cattle, but this 
might be related to increased exposure rather than to 
increased susceptibility (1.3).
Pathology
Cattle chronically infected with paratuberculosis 
develop marked thickening and non-stretchable rugal 
corrugation of the mucosal surface of the affected portions 
of the intestines. The lesions are usually confined to the 
ileum and upper small intestine but the disease may involve 
the entire small intestinal tract and colon. There is also 
mesenteric lymphadenopathy, with the mesenteric lymph nodes 
being the earliest organs in which the organisms and 
lesions can be detected following experimental infection
(1.16,1.22). Cording of the subserosal and mesenteric 
lymphatics may be observed due to obstruction of the 
lymphatic flow.
In approximately one third of clinical cases of 
paratuberculosis, calcification of the endocardium and/or 
aorta occurs (1.23). The cause of this lesion is unknown
but may be related to an activation of circulating 
macrophages which produce vitamin D3 as a side product 
(1.23).
Histologically, the intestinal thickening and mucosal 
corrugation is due to marked infiltration of the tissues 
with epithelioid macrophages (1.2). Although there is 
variation between cases, the typical lesion has multifocal 
to diffuse infiltration with macrophages and Langhans-type 
multinucleated giant cells in both the intestines and 
mesenteric lymph nodes (1.16). Macrophages usually 
infiltrate and distend the lamina propria and submucosa cf 
the small intestine and colon. These macrophages and giant 
cells contain variable numbers of acid-fast bacilli (1.16). 
Macrophages and giant cells may also be observed in the 
stroma of the muscularis mucosa and the serosa (1.24). In 
affected regions, intestinal villi are shortened and 
distorted (1.24). Lymphatic vessels in the lamina propria 
are often dilated and occasionally ruptured (1.24). 
Microscopic lesions are usually limited to the intestine, 
mesenteric and ileocecal lymph nodes, but occasionally 
extra-intestinal lesions may occur.
The spectrum of lesions in ruminant paratuberculosis 
has been compared to the spectrum of lesions observed in 
human leprosy patients (1.16,1.25). The tuberculoid end of 
the leprosy spectrum is characterized by granulomas with 
necrosis, fibrosis, numerous Langhans giant cells, and very
few detectable acid-fast bacilli, while the lepromatous 
pole is characterized by numerous acid-fast bacilli and 
abundant histiocytes and epithelioid macrophages, with 
minimal necrosis or fibrosis (1.16,1.25). This spectrum is 
also seen in paratuberculosis and although not yet proven 
for cattle, may correspond to the immunologic status of the 
host (1.16). The differences in the lesions suggest that 
there are varying degrees of cell-mediated immunity 
expressed in individual infected cattle. It is not known 
whether these variable degrees of immunity are the result 
of alternating changes in the immune status of the infected 
individual, or of genetic predispositions of certain cattle 
to develop a stronger cell-mediated immune response.
Diagnosis
Immunologic Methods
Although numerous attempts have been made, there is 
still a lack of a reliable test for detection of animals 
infected with IL paratuberculosis. Most tests for the 
presence of infection have either poor sensitivity, poor 
specificity, or both. Previous diagnostic methods that 
have been used or evaluated include the intradermal and 
intravenous johnin tests (1.26-30), complement fixation 
(1.31), hemagglutination (1.32), agar gel immunodiffusion 
(1.33,1.34), enzyme-linked immunosorbent assay (1.35-37), 
radioimmunoassay (1.38), indirect fluorescent antibody 
(1.39), lymphocyte transformation (1.40-43), leukocyte
migration inhibition (1.44), lymphocyte stimulation (1.41), 
immunoperoxidase (1.45), mucosal and lymph node biopsy 
(1.46), and fecal culture (1.2,1.47,1.48).
Most of these methods rely on immunological reactions, 
which is actually an indicator of exposure rather than of 
current infection. Furthermore, cross-reactivity occurs 
between paratuberculosis. and other species in the 
Mycobacterium avium-intracellulare (MAI) group, which are 
ubiquitous in the environment (1.49). Tests for anti- 
mycobacterial antibodies that employ crude antigen 
preparations such as protoplasmic extractions or PPD may 
also cross react with other organisms including 
Actinomvcetes spp., Dermatophilus spp., Nocardia spp., 
Streptomvces spp., Corvnebacterium spp., and even fungi 
(1.2,1.50,1.51). Most immunologic assays are therefore 
limited by false-positive reactions and cannot be 
accurately relied upon for the diagnosis of individual 
cattle or eradication programs. To further complicate the 
issue, a state of immunologic tolerance (anergy) frequently 
occurs during the early phase of the infection, in which 
the infected animal exhibits neither delayed 
hypersensitivity or serologic responses (1.1). In 
addition, chronic infection with paratuberculosis may also 
lead to a state of anergy, which means that even heavily- 
infected animals may test negative when immunologic-based 
assays are used (1 .2 ).
Currently there is a commercially available, pre­
absorbed ELISA test that is apparently more specific for 
Mycobacterium paratuberculosis than previous ELISA's 
(1.52). The Johne's Absorbed EIA (Commonwealth Serum 
Laboratories, Parkville, Australia) has an improved 
specificity because it utilizes a pre-absorption step to 
remove antibodies reacting with Mvcobacterium phlei 
antigens, thus reducing the likelihood of cross-reactivity 
with other mycobacteria (1.52). Although this test is more 
reliable than previous diagnostic tests, there is still the 
problem of anergy in chronically infected cows resulting in 
false negatives, regardless of the type of immunologic- 
based test used.
Fecal Culture
The only practical and cost-effective means by which a 
definitive antemortem diagnosis can be made at this time is 
to culture the organism from tissues or feces. Fecal 
culture has been called the "gold standard" of 
paratuberculosis testing due to its presumed 1 0 0% 
specificity (1.48,1.53). It is also used as the standard 
by which other assays are most often compared. If 
performed correctly, fecal cultures are considered to be 
the most sensitive and specific test to detect infected 
cattle (1.48,1.53). However, even this may be challenged 
as it has been recently shown that uninfected adult cattle 
may pass Mycobacterium paratuberculosis in their feces
9when orally inoculated with the organism (1.54). Although 
this is probably a rare occurrence, this suggests that 
normal, uninfected cattle grazing on infected pastures 
might passively excrete the organism in feces, resulting in 
false-positive culture results (1.54).
Although fecal culture is currently the most specific 
and sensitive test for paratuberculosis (1.48), the long 
incubation period of the organism (weeks to months) makes 
this method an unsuitable diagnostic test for eradication 
programs. In addition, a minimum of 10-100 viable 
Mycobacterium paratuberculosis organisms must be present 
per gram of feces before culture techniques can detect 
infected animals (1.55).
Polymerase Chain Reaction (PCR) Testing
More recent methods of diagnosing paratuberculosis 
are focusing on the polymerase chain reaction (PCR) which 
can detect smaller numbers of Mycobacterium 
paratuberculosis in feces or tissues (1.56-58). Once 
perfected and commercially available, these methods will be 
able to detect Mycobacterium paratuberculosis DNA in the 
feces of infected animals in a matter of hours, resulting 
in a diagnostic assay that provides almost immediate test 
results and that may eventually exceed the sensitivity of 
fecal culture. Specific sequences of Mycobacterium 
paratuberculosis DNA have already been cloned to use in 
these assays. The insertion sequence IS900 is unique to
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Mycobacterium paratuberculosis and is currently in use as a 
target for a specific and sensitive DNA probe (1.58,1.59). 
This sequence encodes for a single antigenic protein 
referred to as p43, and methods are currently being 
evaluated for using this protein as a diagnostic marker 
(1.59). Comparisons of fecal culture to DNA probe methods, 
however, show that the sensitivity is currently similar in 
both methods (1.55,1.58).
Microbiology
Mycobacterium paratuberculosis. the causative agent of 
paratuberculosis, is a small (0.5/xm x 1.5/zm), acid-fast, 
Gram-positive, non-motile, facultative, rod-shaped bacillus
(1.2). The organism can remain viable in feces and soil 
for over 11 months (1.2). Although many previous attempts 
had been made, culture of the organism was first achieved 
by enriching the medium with killed tuberculosis bacilli 
(1.14,1.60). It is now generally accepted that all bona 
fide strains of Mycobacterium paratuberculosis are 
mycobactin dependent (1.61). The reverse is not 
necessarily true, as certain strains of the M. 
avium/intracellulare (MAI) complex are also mycobactin 
dependent (1.61). Fortunately, MAI bacilli are 
comparatively rapid growers compared to M. 
paratuberculosis. making the distinction between these 
closely related organisms possible without the use of 
sophisticated techniques (1.61).
The role of iron in the pathogenesis of 
paratuberculosis has been examined (1.61-66), but the 
mechanisms involved are as yet unclear. Like other 
mycobacteria, M. paratuberculosis has a high requirement 
for iron to sustain growth, and has developed mechanisms to 
obtain and transport iron across its cell membranes 
(1.16,1.62). Mycobacteria produce at least two kinds of 
iron binding compounds, mycobactin and exochelin, both of 
which are siderophores utilized to obtain iron from the 
environment (1.63). It has been proposed that lymphatic 
damage and subsequent leakage of lymph into the intestinal 
tissues may provide the higher iron concentration in the 
intestinal tissues required for proliferation of the 
organisms (1.64). Granulomatous lesions of 
paratuberculosis have been shown to contain ferritin, 
lactoferrin, and transferrin (1.63). Studies in mice have 
demonstrated that the severity of the lesions does appear 
to correlate with higher intracellular iron content (1.65). 
On the other hand, supplementation of mice with mycobactin 
J and/or lactoferrin seems to have no effect on the 
multiplication of Mycobacterium paratuberculosis in 
gnotobiotic mice (1.66). Furthermore, mycobactin cannot be 
detected in tissues infected with Mycobacterium 
paratuberculosis suggesting that once inside the host, 
these organisms may utilize different mechanisms to acquire 
iron (1.67).
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Epidemiology
Paratuberculosis is worldwide in distribution and the 
prevalence appears to be increasing in some countries 
(1.3). In England, it is considered to be the most 
economically important infectious disease of cattle (1 .1 ). 
In the United States, the disease is present wherever there 
are large concentrations of cattle (1.2,1.68-69).
Reliable estimates of the actual prevalence of the 
disease are difficult to obtain due to the insidious nature 
of the disease, the non-specificity of its clinical signs, 
and the lack of reliable diagnostic testing procedures.
Only in the terminal stages of the disease do animals 
display typical signs of diarrhea and weight loss. Most of 
the losses due to paratuberculosis are from decreased 
productivity and secondary infections that do not prompt 
clinicians or farmers to test for paratuberculosis. Losses 
due to subclinical disease such as decreased production, 
infertility, mastitis and other secondary infections are 
probably the most significant causes of economic losses in 
an infected herd (1.2,1.5,1.21,1.70).
Most estimates of the prevalence were determined by 
the isolation of M^ . paratuberculosis from tissue specimens 
(usually ileocecal lymph nodes) obtained from cattle at 
slaughter (1.71). One extensive survey found that the 
overall prevalence of paratuberculosis in the United States 
was 2.9% of the dairy cattle and 0.8% of the beef cattle
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(1.6% overall) (1.72). This is probably an underestimation 
of the true prevalence, since the methods used in the study 
utilized strong decontamination media (benzalkonium 
chloride and/or hexadecylpyridinium chloride) which may 
have killed many mycobacteria in the specimens, resulting 
in false negatives. Other studies indicate that at least 
in certain parts of the United States, the prevalence of 
paratuberculosis is much higher. A Wisconsin study found 
that 1 1% of the cattle were infected with paratuberculosis 
(1.73). Another study that combined culture results with 
histologic examination indicated that over 18% of the 
cattle in the New England states are infected (1.74).
Most of these surveys report a higher incidence of 
paratuberculosis in dairy cattle than in beef cattle 
(1.71). This might be attributed to the methods of 
husbandry, since dairy cows are usually kept in closer 
confinement, resulting in higher levels of fecal 
contamination and exposure (1.75). In addition, slaughter 
house studies are based entirely upon cows sent to 
slaughter, and the selection process for sending cows to 
slaughter varies between dairy and beef cattle (1.75).
Dairy cattle that are sent to slaughter are usually 
debilitated or have decreased milk production (1.75) and 
therefore cows with paratuberculosis would be over­
represented in this group. In areas where beef cattle 
populations greatly exceed dairy cattle populations,
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paratuberculosis is more prevalent in the former (1.75).
At this time, with the limited studies that have been 
performed, a breed predilection in susceptibility to the 
disease has not been proven (1 .2 ) but there may, however, 
prove to be a genetically-linked susceptibility in cows 
analogous to the Beg gene-associated susceptibility to 
mycobacterial diseases in mice.
Economic Significance 
Estimates of the financial losses to the beef and 
dairy industries due to paratuberculosis vary. The 
economic losses in New England alone have been estimated at 
over $15.4 million per year (1.74). Economic losses in 
Pennsylvania and New York have been estimated at $5.8 and 
$6.4 million annually, respectively (1.71). The Central 
Animal Health Laboratory has estimated losses to the 
Wisconsin dairy industry to exceed over $52 million per 
year (1.71). This means that based upon these surveys, a 
farmer with an infected herd can expect annual losses of 
$75 to $100 per adult cow (1.2). Calculations of expected 
versus actual production in paratuberculosis infected dairy 
herds reveal that there is an 8% reduction of total milk 
production and a 30% decrease in slaughter value of culled 
cows (1.71). Since the current value of an average adult 
dairy cow is only $1200 (1.71), continuous losses due to 
paratuberculosis may be devastating to the average farmer.
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Transmission
Infection with Mycobacterium paratuberculosis is 
initially acquired by oral ingestion of the bacilli by 
young calves* usually less than three months of age (1 .2 ). 
Inoculation of adult cows fails to cause successful 
infection or results in mild or inapparent infections
(1.2). The reason for the selective susceptibility of 
young calves to infection is not known.
It is widely accepted that infection occurs when 
calves nurse on teats contaminated with feces (1 .1 ,1 .2 ). 
However, bacilli may also be ingested from contaminated 
pastures or fomites (1.2). In addition, recent studies 
have shown that both clinically and subclinically infected 
cows actually shed the organisms in their milk (1.76). 
Mycobacterium paratuberculosis has also been cultured from 
the fetuses of both infected cows showing clinical signs of 
paratuberculosis (1.7,1.77-80) and cows not manifesting 
clinical signs of the disease (1.81). Although no cases of 
vertical transmission resulting in clinical disease have 
been proven, shedding of bacilli in the milk and/or in 
utero infection might be important methods of transmitting 
the disease.
Pathogenesis
Once ingested , M. paratuberculosis enters the gut- 
associated lymphoid tissues (GALT) through infection of the 
tonsils or the Peyer's patches (1.22). The organism
selectively enters these sites by invading and traversing 
the specialized intestinal epithelial cells called M cells 
that completely cover the domes of lymphoid follicles in 
the ruminant GALT tissues (1.82,1.83). The reason bacilli 
are selectively taken up by these cells is currently 
unknown, but only live bacteria are taken up by M cells, 
suggesting that the process is actively initiated by the 
bacilli (1.83). It has recently been shown that M. 
paratuberculosis binds to fibronectin, an adhesive 
glycoprotein expressed on host cell surfaces (1.84). This 
binding was shown to be specific for fibronectin, and not 
present in other mycobacterial species tested (M^ . phlei) 
(1.84) . This suggests that entry of M_j_ paratuberculosis 
into host cells may be a specific, host-adapted, receptor- 
mediated event.
Once across the epithelium, M. paratuberculosis is 
phagocytized by macrophages, in which it survives and 
replicates intracellularly, being protected from humoral 
and cell-mediated immune systems (1.1). The organisms may 
localize in the submucosa of the ileocecal tissue, or they 
may be transported to the mesenteric lymph nodes
(1.2,1.16,1.22). One hypothesis states that bacterial 
replication occurs initially within the mesenteric lymph 
nodes, and the intestines may not be involved until late in 
the course of the disease (1.22). This hypothesis is based 
upon the observation that in experimentally infected
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cattle, granulomatous lesions and detectable acid-fast 
bacilli are first found in the mesenteric lymph nodes 
rather than the intestines (1.22). Little is actually 
known of the pathogenesis of the disease beyond the entry 
stage, but lesions and bacterial proliferation are almost 
always limited to the intestines and associated lymph nodes
(1 .2 ), suggesting a bacterial predilection for these sites. 
This may be related to the organism's unusually high 
requirement for exogenous sources of iron (1.16,1.62) which 
it might acquire directly from the hosts gastrointestinal 
tract.
Once the infection has commenced, bacterial 
replication seems to progress unimpaired. Although none of 
the classical, known cell toxins are produced by the 
bacteria, the ability to survive and replicate within 
macrophages seems to be the organism's most damaging 
virulence factor (1.1). Factors have been isolated from M. 
paratuberculosis that seem to have deleterious effects on 
the macrophage's ability to kill Candida albicans (1.85). 
Although these factors have not yet been completely 
identified, they seem to be similar to factors of other 
mycobacteria such as the lipoarabinomannan of M. leprae and 
M. tuberculosis which has been shown to inhibit the 
activation of macrophages (1.86). These factors may play a 
role in impairing the macrophage's ability to destroy the 
mycobacteria as well (1 .8 6 ).
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Following infection, recruitment of macrophages into 
the lesions occurs, probably due to the effects of soluble 
factors (cytokines) released from infected cells (1 .2 ).
This granulomatous inflammation results in distortion of 
the tissue architecture and impairment of function (1 .2 ). 
Blood and lymphatic vasculature drainage is compromised
(1 .2 ) and plasma leakage from the gastrointestinal tract 
occurs, resulting in decreased serum protein and an 
increase in protein catabolism (1.87). These factors, 
along with a general intestinal malabsorption due to the 
granulomatous tissue infiltration result in the severe 
weight loss and cachexia typical of the terminal stages of 
the disease (1 .2 ).
Treatment
To date, there are no cost-effective or practical 
treatments for paratuberculosis. Although the bacillus is 
susceptible to many bacterial agents in vitro, 
chemotherapeutic trials in vivo have not been successful
(1.2). In most cases, treated animals transiently improve 
clinically but continue to shed the bacillus and eventually 
succumb to the disease (1.2). The most effective drug 
studied thus far in vivo has been clofazamine (1.1). This 
drug reduces the clinical signs of illness and decreases 
fecal shedding of the bacilli by infected ruminants, but 
relapse occurs if the drug is withdrawn, even after 2 0 0  
days of treatment (1.1). Therapeutic trials on mice have
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shown that rifabutin may decrease M. paratuberculosis 
counts, but clearance of the bacteria does not occur, even 
after 6 months of therapy (1 .8 8 ).
Although treatment of paratuberculosis is not yet a 
viable alternative, the development of new 
antimycobacterial agents and strategies might provide help 
in combating this disease in the future. Combination 
therapy, often used against M. tuberculosis, has not yet 
been evaluated against M. paratuberculosis in vivo. Recent 
reports have shown that combination therapy of 
clarithromycin and ethambutol is significantly more 
effective against M. paratuberculosis in vitro than either 
of the two antibiotics when used alone.
Prevention
Prevention of paratuberculosis is difficult in that it 
is currently centered on time-consuming husbandry and 
management practices (1.1,1.2). Calves are removed from 
the dams immediately after birth and bottle-fed milk 
replacers and colostrum from paratuberculosis-free cows
(1.1,1.2). Fecal cultures or immunologic tests are 
routinely performed on adults and positive reactors are 
removed from the herd (1.2). Cleaning and disposal of 
fecal material is also an important step in reducing 
bacterial contamination and spread (1 .1 ,1 .2 ).
There are a number of both attenuated and killed 
vaccines available for paratuberculosis, but the efficacy
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and ethics of their use is controversial (1.2). The use of 
either type of vaccine appears to result in a reduction of 
the number of animals demonstrating clinical signs, yet 
these animals continue to shed viable bacilli, thus 
contributing to environmental contamination (1 .2 ).
Husbandry and control measures are required to obtain 
maximum benefits (1.2). More importantly, vaccination does 
not confer absolute immunity to the disease (1 .2 ).
Numerous reports suggest that the type of soil may 
determine whether Johne's disease will be a serious problem 
(1.16,1.89,1.90). Clinical cases of Johne's disease do not 
seem to occur in cattle raised on soils with high pH or a 
high lime (calcium carbonate) content (1.89,1.90).
Although some lesions and acid-fast bacteria occur 
regardless of soil type, the clinical features of Johne's 
disease; diarrhea and weight loss, do not seem to be a 
problem in cows raised on alkaline soils (1.16).
Alkalinization of the soil in endemic areas by the 
addition of crushed limestone has been incorporated into 
the Environmental Paratuberculosis Inhibition Concept 
(EPIC) guidelines as an integral part of the procedures 
recommended to control paratuberculosis in endemic areas 
(1.89) .
Laboratory Animal Models for Paratuberculosis
The apparent lack of a suitable laboratory animal 
model for paratuberculosis has hampered research into the
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immunology, pathogenesis and therapeutics of the disease. 
The literature describing the susceptibility of laboratory 
animals to paratuberculosis is confusing and often 
conflicting (1.91,1.92). Failure to successfully infect 
cats, guinea pigs, mice, rabbits, rats, hens, pigeons, 
gerbils, and hamsters with paratuberculosis (or M. 
johnei) has been reported (1.14,1.92-101,1.26). Some of 
these researchers were successful with one species but 
failed with another, while other researchers using the same 
species would achieve opposite results.
Rabbits were the first laboratory animals that were 
shown to develop classical lesions of Johne's disease 
following an experimental inoculation of M.
paratuberculosis (1.14,1.92.1.96) Thickening and folding of 
the intestinal mucosa and enlarged intestinal villi packed 
with epithelioid macrophages filled with acid-fast bacilli 
were observed in 25-45% of rabbits after 3-18 months of 
infection (1.92,1.96). However, early studies with rabbits 
were inconsistent, possibly due to variations in the strain 
of rabbit and/or bacilli used, and the route of 
inoculation. Successful infections producing typical 
lesions usually occurred in less than 50% of the animals 
inoculated in the original studies
(1.14,1.92,1.96,1.102,1.103). More recently, orally 
infected rabbits have been demonstrated to be a suitable 
model for producing lesions resembling those of Johne's
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disease in ruminants (1.104). Infections were successfully 
produced in 13 of 21 (62%) rabbits orally inoculated with 
M. paratubercu1osis strain 19698 (1.104). Evidence 
suggests that, if the right strain and a large dosage of 
organism is used, rabbits are a suitable model for studying 
the pathogenesis of paratuberculosis.
Unfortunately, few immunologic reagents are currently 
available for rabbits, which limits detailed investigations 
into the immunology of the disease in this model. A murine 
model of the disease would be less expensive and would 
provide a wider range of research applications.
Many studies have attempted to infect mice with M. 
paratuberculosis but the results have varied between 
experimenters (1.91,1.92,1.105). Part of the paradox in 
the literature regarding the susceptibility of mice may be 
explained by the use of different strains of M. 
paratuberculosis. differences in strains of mice used 
(strains were not even mentioned in some studies (1.105), 
varied routes of inoculation and dosage, and the wide 
variety of substances used as the vehicle to deliver the 
organisms. Although it is now known that there are several 
different strains of It paratuberculosis. most of the 
earlier studies utilized wild-type strains isolated from 
clinical cases of Johne's disease. It is currently known 
that different strains of paratuberculosis can behave 
differently in the same laboratory animal (1.91) and
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therefore the use of unclassified strains may produce 
varied results in different species.
Intraperitoneal and intravenous infections have 
resulted in the reproduction of paratuberculosis lesions in 
mice in several studies (1.91,1.92,1.105-107). The 
development of intestinal lesions in susceptible strains of 
mice using these routes of inoculation suggest that M. 
paratuberculosis has a predilection for intestinal tissues. 
Successful infections using oral routes of administration 
have been achieved in SCID (1.107) and nude (1.108,1.109) 
mice but the immunocompromised states of these animals may 
preclude their use for certain investigative studies of the 
immune response to infection.
Earlier studies using conventional, immunocompetent 
mice have failed to demonstrate successful rates of 
infections using the oral route of inoculation 
(1.94,1.105,1.106,1.110). However, the strain of mice 
and/or paratuberculosis used in some of these 
experiments are unclear, and the genotype of the mice used 
in all of the earlier studies was unknown (1.94,1.105).
The inability to infect mice with Mj. paratuberculosis in 
earlier studies may have been due to the failure to use 
genetically-defined strains of susceptible mice. It is now 
known that different strains of mice vary in their 
resistance to mycobacterial diseases, depending upon their 
genotype (1 .1 1 1 ).
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Genetic Regulation of Mycobacterial infections
The theory that genetic factors are important in the 
susceptibility to mycobacterial infections has been 
proposed for years (1.111). However, most of the evidence 
that supports the role of a genetic basis for 
susceptibility to tuberculosis and related mycobacterial 
infections in humans has been circumstantial (1 .1 1 1 ). 
Differences in racial susceptibility (1.112), similarities 
in the susceptibilities of twins (1.113), and associations 
with specific chromosomal markers (1.114), have been 
described for tuberculosis patients. It should be noted 
however, that resistance to mycobacterial infections is 
multifactorial, and whether or not an individual is 
susceptible to infection probably depends upon many other 
factors as well, such as the general immune status of the 
host, and the dose and route of exposure of the organism.
Although actual proof for a genetic basis for 
susceptibility to mycobacterial infections in humans is 
currently lacking, the association of certain genotypes 
with susceptibility to tuberculosis has been known to exist 
in rabbits since the 1930's (1.111). Rabbits were 
selectively inbred for their susceptibility to 
tuberculosis, and it was shown that tuberculosis resistance 
is dominant, multiple, and additive over that of 
susceptibility (1.111.1.115).
Strain variation in the susceptibility of mice to 
mycobacterial infections has been known since the 1940's 
(1.111). Survival times of various mouse strains infected 
with Mi. tuberculosis vary considerably (1.116-1.118). 
Patterns of resistance to tuberculosis in the progenitors 
of C57BL/6J (susceptible) and Swiss (resistant) mice 
suggested that the resistance was controlled by a single 
dominant gene (1.119). More extensive studies utilizing M. 
bpvis/bacille Calmette-Geurin (BCG) infections demonstrated 
that different strains of inbred mice could be distinctly 
separated into either resistant or susceptible categories: 
resistant strains with no or marginal bacterial growth, and 
susceptible strains that allowed uncontrolled bacterial 
proliferation of the bacteria (1.120). Further 
investigation of this differential susceptibility led to 
the discovery of a single autosomal gene (Beg) located on 
chromosome 1 of the mouse, which is expressed in two 
allelic forms referred to as the dominant, resistance 
allele {Beg') and the recessive, susceptibility allele 
(Beg5) (1.121). This gene also controls innate resistance 
to M. lepraemurium. M. intracellulare. M. smegmatis. and M. 
avium and is apparently identical to the Lsh and Jty loci 
which control innate resistance to infection with 
Leishmania donovani and Salmonella typhimurium.
respectively (1 .1 2 2).
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Inbred mice strains of the Beg* genotype include 
BALB/c, DBA/1, C57BL/6, C57BL/10, and CE/J, while the 
resistant genotype includes strains A/J, AKR, C3H/He, 
C57BR/J, C57L/J, CBA, DBA/2, and 129/J (1.123).
The comparative susceptibility of C57, CBA, and Swiss 
mice to an intraperitoneal infection with Mycobacterium 
paratuberculosis has previously been studied (1 .1 1 0 ).
These experiments showed that C57 were indeed more 
susceptible to infection, with Swiss mice being less so, 
and CBA being relatively resistant (1.110). Later 
experiments, however, failed to demonstrate successful 
infection of C57 mice using an oral route of inoculation 
(1.106). However, this study predated the discovery of the 
Beg gene and the Beg genotype of the C57 mice strain used 
in those experiments was not known. It is now known for 
example, that the inbred strains C57BL/6 and C57BL/10 are 
susceptible, yet C57BR and C57L are resistant (1.123). In 
addition, the duration of the infection in question was 
terminated at 9 months, and more importantly, the 
mesenteric lymph nodes (which proved to be of particular 
importance in the present studies - see chapter 2 ) were not 
examined (1.106).
The susceptibility of C3H/HeJ, C57BL/6J, and a number 
of recombinant inbred strains of mice to an intravenous 
infection with M. paratuberculosis has also been compared 
using the number of hepatic granulomas as an index (1.124).
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A correlation was shown between Beg genotype and 
susceptibility in response to the infection as determined 
by histologic counts of hepatic granulomas developing after 
50 days of infection. Although actual bacterial numbers 
were not determined, this study demonstrated that 
resistance to M. paratuberculosis. like other mycobacterial 
diseases, is associated with the Beg gene (1.124).
Although specific strains of mice may be sharply 
divided into susceptible and resistant categories, there 
are some discrepancies in the theory that mycobacterial 
resistance is under the absolute control of a single gene. 
Differences in the susceptibilities of BALB/c, C57BL/6 and 
C57BL/10 mice to an intraperitoneal infection with M. 
paratuberculosis have recently been reported (1.91). 
Although these strains all have the Beg susceptible 
genotype, BALB/c mice were shown to be relatively more 
susceptible to infection than C57BL/10 mice, while C57BL/6 
mice were of intermediate susceptibility (1.91). This 
suggests that even among inbred mice, resistance to 
mycobacterial infections is probably multifactoral and 
deserves further investigation.
The mechanism(s) by which the Beg alleles confer 
resistance or susceptibility are not known. Macrophages 
from BcgT mice are superior to Beg* macrophages in H202 and 
02' production, and hexose monophosphate shunt activity when 
challenged with BCG (1.121). However, macrophage killing
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of mycobacteria does not seem to be dependent upon 
oxidative killing mechanisms (1.121,1.125). Furthermore, 
although antimycobacterial activity is inherently stronger 
in Begr macrophages, Beg* macrophages can be stimulated by 
cytokines to a level of anti-mycobacterial activity that 
equals that of the Beg* macrophages (1.125). Both 
genetically resistant and cytokine-stimulated susceptible 
macrophages have been demonstrated to have equal abilities 
in killing of M. smecrmatis in vitro (1.125). Macrophage 
populations isolated from normal, uninfected, Bcgr mice 
always contained more Ia+ (MHC 11+) cells than their Beg* 
counterparts (1.121). Furthermore, the frequency of Ia+ 
macrophages increases in response to an infection with M. 
bovis/BCG in Beg' but not in Beg* mice (1.121). Antigen 
presentation to T cells is also enhanced in Begr 
macrophages as compared to Beg* macrophages (1.121). In 
addition, more antigen-specific T cell proliferation and 
increased IL-2 production has been observed in Beg* mice 
compared to Bcgr3 mice (1.121). This suggests that the Beg 
gene may exert its effects at the level of macrophage 
activation rather than on an inherent macrophage killing 
function. This defect (in susceptible animals) may either 
be in the macrophage, T cell, or cytokine production 
capabilities of either cell.
Although the equivalent of the Beg gene of mice has 
not yet been described in humans or cattle, conservation of
genes between humans, cattle, and mice is well documented
(1.124.1.126). Currently the product of the Beg gene is not 
known, but it is closely linked in the mouse chromosome to 
the genes for isocitrate dehydrogenase, gamma crystalline, 
and fibronectin (1.124,1.126,1.127). These genes are 
located on the human chromosome 2q and bovine chromosome 8
(1.126.1.127). Since gene homology is often conserved in 
segments, there may be an equivalent gene in both humans 
and cattle that encodes for mycobacterial susceptibility. 
Studies are currently attempting to identify a human 
homologue of the Beg gene (1.121). If this gene is present 
and identifiable in cattle, perhaps paratuberculosis and 
several other important diseases of ruminants, such as 
Salmonellosis, could be eliminated by selectively breeding 
for resistant animals.
Immunology of Paratuberculosis
Very little is currently known about the immunology of 
paratuberculosis as compared to other mycobacterial 
diseases such as tuberculosis, leprosy, or It avium 
infections. The few immunologic studies that have been 
performed in paratuberculosis have focused primarily on the 
quest to develop immunologic diagnostic tests for the 
disease.
Immunity to paratuberculosis, like other mycobacterial 
diseases, is dependent upon cell-mediated immune (CMI) 
responses (1.128). Humoral immune responses have little or
no protective effect (1.128). Immunity to paratuberculosis 
is probably dependent upon the activation of antigen- 
specific T cells that induce the CMI response of 
mononuclear phagocytes, resulting in macrophage activation 
and killing of phagocytized mycobacteria (1.128). In 
tuberculosis, both CMI and delayed-type hypersensitivity 
(DTH) play a role in mycobacterial clearance (1.129). The 
CMI is responsible for macrophage activation resulting in 
the destruction of ingested bacilli, while the DTH response 
results in tissue necrosis and the destruction of 
mycobacterial infected macrophages, releasing them from 
their protected intracytoplasmic environment (1.129). 
Although some tissue necrosis is reported in the infected 
tissues of small ruminants (deer, sheep, and goats) the DTH 
response is absent in the intestinal tissues of infected 
cattle and probably does not play as significant a role in 
resistance to the infection in the target tissues (1 .2 ). 
Although DTH responses in the skin occur in some cattle 
with paratuberculosis (1.2,1.26-30), this phenomenon does 
not appear to occur in the tissues where the organism 
resides (1.128). This is probably due to the 
compartmentalization of the gut-associated lymphoid tissues 
(GALT) (1.128) .
Paratuberculosis is unique in that proliferation of 
the organism is usually limited to the intestinal tissues 
and associated lymph nodes, and resistance to the organism
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is therefore probably under the exclusive control of the 
GALT (1.128).
The GALT are believed to operate differently from the 
systemic immune system (1.128). Sometimes the GALT immune 
response is actually opposite to the systemic response 
(1.130). Evidence for this is the oral tolerance 
phenomenon, which suppresses the systemic immune system to 
orally presented antigens (1.130). Furthermore, the immune 
response of the GALT is essentially compartmentalized
(1.128). Although lymphocytes primed in the intestinal 
tissues transiently circulate, they will eventually return 
to the tissues in which they were activated (1.131). 
Lymphocytes that encounter antigen either in the lamina 
propria or Peyer's patches of the intestine will 
temporarily leave the intestines, drain to the mesenteric 
lymph nodes, and eventually reach the systemic circulation
(1.128,1.131). These cells will eventually, however, 
return to the intestinal tissues and disperse throughout 
the mucosa, resulting in the spread of these specific 
antigen-activated lymphocytes throughout the intestinal 
tract (1.128,1.131). This cellular homing to the tissues 
of origin is dependent upon specific cell surface homing 
receptors that bind to complementary ligands expressed on 
high endothelial venules (HEV) (1.131). This homing 
results in specifically primed lymphocytes being returned 
to the tissues from where the antigen was first
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encountered, probably as a means of both conserving immune 
cells, and of targeting the specific tissues where the 
antigen is present.
There are unique features of the GALT of ruminants 
that may play a key role in the unique susceptibility of 
these animals to Mycobacterium paratuberculosis infection
(1.128). Although all mammals have Peyer's patches, the 
Peyer's patches of ruminants are unique compared to those 
of other animals in that there are two different types
(1.128.1.132). The jejunal Peyer's patches are similar to 
those of other species in that they are not present until 
after birth and seem to develop in response to antigenic 
stimulus (1.128,1.132). The ileal Peyer's patches, on the 
other hand are thought to be a primary lymphoid organ 
similar to the bursa of Fabricus in birds, which is 
important in the generation of lymphocytes, rather than 
simply being the sites of lymphocyte activation or priming
(1.128.1.132). If so, the generation of lymphocytes in 
these areas may be important in the pathogenesis of 
disease. If, for example, foreign antigens such as 
mycobacteria or other infectious agents are encountered 
during the developmental stages of lymphocytes, they may 
fail to recognize these antigens as foreign, and become 
tolerant to them. Another possibility is that 
mycobacterial antigens induce a state of immunologic 
unresponsiveness in the intestines via mechanisms similar
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to those involved in the oral tolerance phenomenon (1.128). 
This are two hypotheses that could explain the enhanced 
susceptibility of young calves to paratuberculosis.
Gamma Delta T Cells and Mycobacterial Disease
In most animal tissues, the vast majority of T cells 
express a heterodimer consisting of two polypeptide chains 
referred to as the alpha/beta T cell receptor (aj8 TCR)
(1.133). This receptor serves as the antigen recognition 
and binding site for the cell (1.133). Included amongst 
the a/3 T cells are the T cell subsets commonly referred to 
as the helper/inducer (CD4+) T cells and most of the 
cytotoxic/suppressor (CD8+) T cells. However, in 1984, a 
second subset of T cells were identified that express a 
unique set of polypeptide subunits, now referred to as the 
gamma/delta T cell receptor (7 S TCR)(1.134). These cells 
differ in many respects from the a/3 T cells with regard to 
their ontogeny, side-chain diversity, and anatomic location 
(1.135). Although little is presently known about the 
functional characteristics of these cells, their prominence 
in epithelial surfaces strongly suggests that they play a 
role in the surveillance of the mucosal epithelium to 
invading pathogens (1.135,1.136).
To date, 7 S T cells have been found in every species 
in which they have been sought (1.137). In most species, 
including mice and humans, these cells are found almost 
exclusively in the intestinal tract and epithelial surfaces
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(1.135,1.137). Young ruminants, however, have strikingly 
different proportions of circulating yS T cells compared to 
other species (1.138). Up to 75% of the total circulating 
lymphocytes of 2 -week-old ruminants are yS+ T cells 
(1.138). The prominence of yS T cells in these ruminants 
decreases with age, as three month old animals have 
peripheral lymphocyte percentages measuring 30%, and those 
5 and 10 years of age have peripheral yS T cell proportions 
of 10% and 5% respectively (1.138). Although it may be 
incidental, the prominence of this cell population in the 
ruminant might prove to be important in the susceptibility 
and/or pathogenesis of Mycobacterium paratuberculosis.
Since their discovery, several studies have implicated 
an involvement for yS T cells in the immune response to 
mycobacteria (1.139-1.141). In vivo experiments have 
demonstrated up to 28-fold increases in the numbers of yS T 
cells in the draining lymph nodes of mice vaccinated with 
M. tuberculosis in Freund's adjuvant (1.139). Increased 
numbers of yS T cells have also been detected in the lungs 
of mice aerosolized with mycobacterial purified protein 
derivative (PPD) (1.142). Increased numbers of yS T cells 
can also be found in the skin of certain types of leprosy 
lesions (1.143). Furthermore, several studies have shown 
proliferative responses of yS T cells to mycobacterial 
products or their fractions (1.140-1.146).
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Although there is a clear association between 
mycobacterial diseases and yS T cells, little is known 
about the role these cells play in infection. Since the 
majority of these cells reside in or near epithelial 
surfaces, it has been suggested they may play a protective 
role against pathogens that may be encountered in damaged 
epithelium (1.135,1.137).
The majority of yS T cells from the intestinal 
epithelial lymphocyte (IEL) population also co-express CD8 , 
suggesting they may play a cytotoxic role, and cytotoxic 
activity of these IEL's has been demonstrated both in vivo 
and in vitro (1.147). Furthermore, IEL derived yS T cells 
are capable of reversing orally induced systemic 
unresponsiveness to certain antigens (sheep red blood 
cells) when adoptively transferred to mice orally tolerized 
with these antigens (1.147). However, both IL-5 and IFN-7 
production has been demonstrated by murine 7 5+ IEL's, 
suggesting that they may also play a helper or regulatory 
role (1.148). This suggests that 7 S T cells of the IEL 
population may have properties of both Thl and Th2 type 
effector cells.
Lymphocytes expressing the 7 S TCR isolated from 
extra-intestinal sources have different properties than 
those from the IEL's (1.148-150). First, there is 
different gene usage between 7 S T cells of the intestine 
and those of the skin (1.149). In addition, co-expression
of both CD8 and yS TCR seems to be limited to the IEL's, as 
CD8+, yS TCR+ (double-positive) cells are rare in epidermal 
or extraintestinal tissues (1.149). Furthermore, yS T 
cells from the intestines seem to be generated from within 
the intestinal tissues, whereas all other yS T cells (and 
other known T cells) are derived from the thymus (1.149). 
Finally, differences in cytokine production have been 
demonstrated between yS T cells of the IEL's and those from 
other tissues (1.148,1.150). Gamma/delta T cell lines 
derived from lymph nodes can produce IL-2, IL-3, GM-CSF, 
and IFN-y (1.150). These y<S+ T cell lines do not produce 
IL-4 nor IL-5, suggesting that they play more of a Thl type 
role (1.150). On the other hand, these cell lines do 
express the IL-4 receptor (IL-4Rc) and require IL-4 
stimulation to transfer delayed-type hypersensitivity 
reactions in the skin (1.150).
Objectives
The immunological reactions that occur throughout the 
course of infection with M. paratuberculosis have not been 
evaluated. Economics is one of the major reasons for this, 
since the long incubation period of the disease, combined 
with the cost of maintaining a significant number of 
infected cattle is cost prohibitive for most investigators. 
Previous attempts to define a suitable laboratory animal 
model for paratuberculosis, (many of which were performed 
over 40 years ago) were often contradictory and confusing.
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However, developments in genetic technology, the 
development of inbred mouse strains, and recent advances in 
the pathogenesis of other mycobacterial diseases have shown 
that mycobacterial resistance has a genetic component, 
which may explain earlier failures to infect mice. Recent 
evidence suggests that immunity to Mycobacterium 
paratuberculosis in mice may also be genetically linked and 
that once defined, mice may be a suitable laboratory animal 
model for studying paratuberculosis.
Objective 1
To demonstrate that resistance to M. paratuberculosis. 
like other mycobacterial diseases, is associated with the 
Beg gene by showing that bacterial clearance occurs in a 
Beg resistant mouse strain, while bacterial proliferation 
occurs in a susceptible strain.
Objective 2
To demonstrate that susceptible mouse strains 
eventually develop lesions resembling those of the natural 
disease in ruminants and therefore may be used as a 
suitable model for studying the pathogenesis of the disease 
in all stages of the infection.
Objective 3
To determine whether immunological differences exist 
between the two strains of mice in response to infection 
with M. paratuberculosis using the following immunologic 
techniques and methods:
a) Measurement of levels of non-specific macrophage 
activation in response to the infection by use of a 
Listeria sp. challenge assay.
b) Evaluation of the kinetics of the T cell response 
throughout the course of the infection in several 
immunologic organs to determine whether there are 
significant differences in the proportions of CD3, CD4, 
CD8 , and/or yS T cells between the two strains of mice in 
response to infection.
c) Determination of changes in levels of lymphocyte 
activation in response to the infection by assessing the 
percentages of CD44+ and CD25+ cells responding to the 
infection.
d) Determination of differences in the production of IL-2 
and/or IL-4 in response to exposure of cells of each mouse 
to M. paratuberculosis in vitro.
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CHAPTER 2. COMPARATIVE SUSCEPTIBILITY OF C57BL/6 AND 
C3H/He MICE TO INFECTION WITH 
MYCOBACTERIUM PARATUBERCULOSIS
Introduction
Paratuberculosis (Johne's disease) is a chronic, 
granulomatous, intestinal disease of ruminants caused by 
the acid-fast bacterium Mycobacterium paratuberculosis. 
Clinically, the disease is characterized by progressive 
weight loss and intractable diarrhea (2.1). Ruminants are 
infected at a young age, but several months to years may 
elapse before clinical signs are detected (2.1). The 
disease occurs throughout the world and is endemic in the 
United States (2.1). Estimates of the prevalence in this 
country range from 3-17% in culled dairy cattle (2.1).
The lack of a suitable laboratory animal model for 
ruminant paratuberculosis has hampered research into the 
immunology and pathogenesis of this disease. The 
literature on the susceptibility of laboratory animals to 
M. paratuberculosis is confusing and often conflicting 
(2.1,2.3). Failure to successfully infect cats, guinea 
pigs, mice, rabbits, rats, hens, pigeons, gerbils, and 
hamsters with paratuberculosis (or M-_ iohnei) has been 
reported (2.3-2.14). Some researchers were successful in 
infecting one species but failed with another, while others 
could not duplicate some of these infections.
Much of the confusion in the use of mice and rabbits 
may now be explained by the variable susceptibility of
53
54
animals with different genotypes to mycobacterial 
infections. It is now known that resistance to several 
mycobacterial infections in mice and rabbits is associated 
with the Beg gene (2.15-2.17). Previous failures to infect 
these animals with M. paratuberculosis might have been due 
to the inadvertent use of genotypically resistant strains 
of animals. Rabbits have recently been shown to be an 
acceptable laboratory animal model for studying the entry 
and pathogenesis of paratuberculosis (2.18), but the lack 
of commercially available reagents to lymphocytes in the 
rabbit make this a less than optimal model for studying the 
immune responses to the infection.
The comparative susceptibility of C57, CBA, and Swiss 
mice to an intraperitoneal infection with M. 
paratuberculosis has been reported (2.19). These 
experiments showed that C57 mice were more susceptible to 
infection, with Swiss mice being less so, and CBA being 
relatively resistant (2.19). Later experiments, in 
contrast, failed to demonstrate successful infection of C57 
mice using an oral route of inoculation (2.20). This may 
be explained by the use of genetically undefined mice. It 
is now known, for example, that the inbred mouse strains 
designated C57BL/6 and C57BL/10 are Beg susceptible, yet 
C57BR and C57L are Beg resistant (2.21). In addition, the 
duration of the infection in question was terminated at 9 
months, and more importantly, the mesenteric lymph nodes,
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which proved to be of particular importance in the present 
studies, were not examined (2.20).
The susceptibility of C3H/HeJ, C57BL/6J, and a number 
of recombinant inbred strains of mice to an intravenous 
infection with M. paratuberculosis has also recently been 
compared, using the number of hepatic granulomas as an 
index (2.16). A correlation was shown between the Beg 
genotype and susceptibility to the infection as determined 
by histologic counts of liver granulomas developing after 
50 days of infection (2.16). Although actual bacterial 
numbers were not determined, this study determined that 
early resistance to M. paratuberculosis. like other 
mycobacterial diseases, is associated with the Beg gene.
The gut associated lymphoid tissues (GALT) were not 
examined in this study, and therefore no comparisons to the 
natural disease were made. Furthermore, the study was 
terminated at 50 days postinoculation (2.16), and it was 
not determined whether the infection would have progressed 
or have been self-limiting in those mice.
The objectives of the present study were to determine 
whether there were significant differences in the lesions 
and/or persistence of Mycobacterium paratuberculosis in a 
Beg susceptible (Beg3) mouse strain (C57BL/6) compared to a 
Beg resistant (Begr) strain (C3H/He) over a 9 month period 
of infection. To accomplish this, both strains of mice 
were infected with a high, intraperitoneal (ip) dose of M.
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paratuberculosis and incubated at intervals extending up to 
9 months. At the end of the study, the mice were 
sacrificed and M. paratuberculosis colony forming units 
(MCFU) from the spleens were counted. The small and large 
intestines, mesenteric lymph nodes, livers, lungs, kidneys, 
and peritoneal granulomas were also examined 
microscopically for the presence of granulomatous lesions 
containing mycobacteria. For confirmation of the 
mycobacteria, immunohistochemistry was performed on tissues 
containing acid-fast organisms using an anti-Mvcobacterium 
paratuberculosis polyclonal antibody.
Materials and Methods
Animals
Both the C3H/HeN and C57BL/6N mice used in this study 
were originally obtained from Harlan Sprague Dawley, Inc., 
Indianapolis, IN, and bred at the AAALAC accredited, 
Louisiana State University, Division of Laboratory Animal 
Medicine Vivarium. Mice were housed in polypropylene 
rodent boxes ("shoebox" cages) with stainless-steel wire 
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J. 
Murphy Forest Products Corp., Montville NJ). Animals were 
fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis, 
MO) and water ad libitum, and maintained on a 12/12-hour 
light/dark cycle. All mice used in the study were infected 
at 4-6 weeks of age.
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Organism and Preparation of Inoculum
Mycobacterium paratuberculosis ATCC strain 19698 was 
obtained from the USDA-ARS, National Animal Disease Center 
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth 
supplemented with Middlebrook OADC enrichment media (DIFCO 
labs, Detroit MI), 0.2% glycerol (Sigma, St. Louis, MO), 
and 2 mg/liter Mycobactin J (Allied Laboratories, Glenwood 
springs, CO). Broth cultures were incubated at 37°C for 3- 
5 months and bacteria were harvested by centrifugation (10 
minutes at 2 000g), washed 3X in phosphate-buffered saline 
(PBS), sonicated for 10 seconds at 40W (Heat Systems- 
Ultrasonics Inc., Plainview, N.Y.) to reduce clumping, and 
adjusted to 3 X 109 bacteria per dose as determined by 
McFarlands standards. The number of viable bacteria per 
inoculum was later verified by plating serial dilutions on 
Middlebrook 7H10 agar supplemented with OADC and Mycobactin 
J. Mice were inoculated by the intraperitoneal route with 
1 X 109 viable bacilli suspended in 0.3ml PBS. 
Susceptibility Assays
Bacterial CFU from the spleens of infected mice were 
counted after postinoculation intervals ranging from 3 days 
up to 11 months (Table 2.1). Each group consisted of at 
least 4 mice. For bacterial counts, mice were killed by 
cervical dislocation and spleens were aseptically removed 
and placed in 3ml RPMI-1640 on ice. Spleens were 
homogenized using pestle-type tissue homogenizers (Thomas
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Scientific, Swedesboro, NJ), and serial dilutions were 
plated on Middlebrook 7H9 agar supplemented with OADC and 
mycobactin-J. Plates were then sealed in plastic bags and 
incubated at 37°C in a humidified incubator. Bacterial CFU 
were counted after 4 weeks of incubation using a colony 
counter (New Brunswick Scientific, NJ).
Statistical Analysis
Mycobacterial counts were computer analyzed by 
comparative analysis of variance using Tukeys' studentized 
range test. Least square means were compared between each 
group of mice using a pairwise t test. Groups at different 
infection intervals were compared within strains, and those 
at the same infection interval were compared between 
strains.
Gross and Microscopic Pathology
Samples of liver, jejunum, ileocecal valve, colon, 
mesenteric lymph nodes, and peritoneal granulomas (when 
present) were taken from mice that had been inoculated at 
intervals of 5, 10, 15, 30, 226, and 269 days. Tissues 
were fixed in neutral-buffered 10% formalin, and routinely 
paraffin-embedded, sectioned, and stained with H&E and 
Ziehl-Neelsen acid-fast stains. Liver sections were taken 
from the widest part of the left lobe and mesenteric lymph 
nodes were sectioned longitudinally. At least one
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centimeter of each intestinal segment (jejunum, ileum, and 
colon) was examined histologically from each mouse. 
Immunohistochemistry
Formalin-fixed tissues were routinely embedded in 
paraffin and sectioned at 4/xm. Sections were attached to 
silanized slides, dried overnight at 37°, deparaffinized 
through zylene and graded alchohols, and then equilibrated 
with tris-buffered saline. Sections were then stained 
using the avidin-biotin complex method with rabbit, anti- 
Mvcobacterium paratuberculosis polyclonal antibody (Dako, 
Carpinteria, CA).
Results
Microbiology
Equal numbers of viable M. paratuberculosis bacilli 
(as determined by CFU counts) were isolated from the 
spleens of both strains of mice after 3 days of infection 
(Fig. 2.1). Thereafter, the numbers of mycobacteria 
isolated from the Bcgr mice (C3H/He) decreased over the 
course of infection (Fig. 2.1). Significant decreases 
(p<0.05) in the number of bacterial CFU's were detected in 
C3H/He mice that had been infected for 10 days compared to 
those infected for 3 days. By 6 months after infection, 
bacterial numbers in the Bcgr strain had dropped over 100- 
fold. In contrast, no significant decreases in bacterial 
CFU's were observed in the Beg* (C57BL/6) strain. In fact, 
bacterial counts from chronically infected C57BL/6 mice
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Figure 2.1. Comparison of the growth of Mycobacterium 
paratuberculosis in the spleens of Beg resistant (C3H/He) 
and Beg susceptible (C57BL/6) strains of mice. Each point 
represents the mean CFU of 3-9 mice. Error bars represent 
the standard error of the mean.
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were consistently higher than those that had been infected 
for 3 days (Fig. 2.1).
Gross Pathology
Peritoneal granulomas were consistently present in all 
mice that had been infected for more than 10 days but less 
than 5 months. These granulomas were usually small (up to 
3mm diameter), white to yellow, firm, and were usually 
adhered to the peritoneal wall, intestinal serosa, surface 
of the liver, omenta, or diaphragm. Adhesions between the 
intestines, spleen, stomach, and/or liver were frequent.
Mesenteric lymph nodes from C57BL/6 mice infected over 
5 months were often enlarged and firm compared to those 
from C3H/He mice. Marked splenomegaly was present by 10 
days after infection in both strains of mice but this 
usually subsided by 30 days after infection. Interestingly, 
the spleen and Peyer's patches were usually 3-4X larger in 
both control and infected C3H/He mice than in the C57BL/6 
strain.
Microscopic Pathology
Marked differences were observed between infected 
C3H/He mice and C57BL/6 mice in the lesions that developed 
in response to the infection. Numerous (5-10 per mm2) 
granulomas associated with acid-fast bacteria were detected 
in the livers of C57BL/6 mice that had been infected for 10 
days or more, whereas significantly fewer (less than 2 per 
mm2) granulomas were detected in the livers of C3H/He mice
62
of the same pi intervals (Fig. 2.2). Liver lesions in Bcgs 
mice were first evident in the 10 day pi group, and peaked 
in size (up to 200jum in diameter) and number at 15 days of 
infection. Hepatic granulomas were centered around portal 
veins and consisted of mixtures of neutrophils, 
lymphocytes, macrophages, and multinucleated giant cells 
(Fig. 2.2). Several (4-6 per mm2) smaller microgranulomas 
containing acid-fast bacilli were still present in C57BL/6 
mice that had been infected for 9 months but liver lesions 
were essentially absent in chronically infected C3H/He 
mice.
Marked strain differences in the lesions of the 
mesenteric lymph nodes were also detected in infected mice 
(Fig. 2.3). Granulomatous mesenteric lymph node (MLN) 
lesions were consistently present in C57BL/6 mice that had 
been infected for 30 days or more, whereas lesions were 
absent or minimal in C3H/He mice (Fig. 2.3). Severe 
granulomatous lesions containing numerous acid-fast 
bacteria were observed in all C57BL/6 mice infected for 6 
months or more. Occasionally, mild granulomatous lesions 
were observed in the MLN of C3H/He mice infected for 6 
months or less, but these had completely resolved in the 9 
month pi group.
Histological examination of the peritoneal granulomas 
at 5 days pi revealed centers of necrotic cell debris, 
neutrophils, and acid-fast bacteria surrounded by an
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Figure 2.2. Photomicrographs comparing the liver of a 
resistant (C3H/He) mouse (A) to that of a susceptible 
(C57BL/6) mouse (B) 15 days after an intraperitoneal 
infection with 1 X 109 viable Mycobacterium 
paratuberculosis organisms. Note the numerous hepatic 
granulomas (arrows) in the liver of the susceptible mouse. 
H&E stain, bar = 100fim.
Figure 2.3. Photomicrographs comparing the mesenteric 
lymph node of a resistant (C3H/He) mouse (A) to that of a 
susceptible (C57BL/6) mouse (B) 9 months after an 
intraperitoneal infection with 1 X 109 viable Mycobacterium 
naratuberculosis. The susceptible mouse has marked 
granulomatous inflammation consisting of numerous 
aggregates of macrophages and multinucleated giant cells 
(arrows) . H&E stain, bar = 100/m.
intense zone of macrophages and lymphocytes. By 30 days 
pi, the granulomas were laminated, with centers containing 
colonies of extracellular, acid-fast bacteria immediately 
surrounded by a zone of necrotic cell debris and 
neutrophils, which was further surrounded by a thick band 
of foamy macrophages (Fig. 2.4). Numerous lymphocytes and 
fibroblasts were present around the periphery of these 
granulomas. Macrophages in the granulomas contained 
numerous acid-fast bacilli. By 6 months, the granulomas 
had resolved into cores of dense, mature fibrous tissue and 
collagen. Macrophages containing acid-fast bacilli were 
still observed in the centers of these granulomas in both 
mouse strains. No histopathological differences were 
detected between the granulomas of the two mouse strains.
Discussion
Paratuberculosis in ruminants is due to the 
persistence and proliferation of Mycobacterium 
paratuberculosis bacilli in the intestine and mesenteric 
lymph nodes of infected cattle (2.1,2.22-23). The disease 
has a long incubation period, as several months to years 
may elapse between the time calves are infected and 
clinical signs occur (2.1,2.22). Although no breed 
predisposition has been proven, it is estimated that only 
1/3 of the young animals exposed to the bacillus become 
chronically infected (2.1). Little is known about the 
immunology and resistance to the organism, partially due to
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Figure 2.4. Photomicrograph of a granuloma in the 
peritoneum of a C57BL/6 mouse 30 days following an 
intraperitoneal infection with 1 X 109 viable Mycobacterium 
paratuberculosis. H&E stain, bar = lOOjxm
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the lack of an acceptable laboratory animal model. Studies 
on the pathogenesis and immunology or paratuberculosis in 
the natural host (ruminants) are limited by the high cost 
of maintaining a statistically significant number of large 
animals throughout such an extended incubation period. If 
determined to be suitable, the use of smaller laboratory 
animals could benefit research into paratuberculosis.
The results of this study document and quantify 
differences in the susceptibility between C57BL/6 and 
C3H/He mice to infection with Mycobacterium 
paratuberculosis. Mice having the Bcgr genotype (C3H/He) 
were able to either kill or at least prevent the 
proliferation of M. paratuberculosis over a 9 month course 
of infection, as determined by the continually declining 
numbers of mycobacterial CFU isolated from the spleens. In 
contrast, bacterial proliferation occurred in the Beg* 
strain (C57BL/6), as CFU were consistently higher in 
spleens from chronically infected mice compared to those 
infected for only 3 days. Furthermore, marked differences 
in the lesions were noted between these two strains of 
mice. Susceptible mice (C57BL/6) developed granulomatous 
lesions in the mesenteric lymph nodes resembling those 
observed in the natural disease of ruminants (Figure 2.3). 
These lesions continually increased in severity over the 
course of the infection. In contrast, no evidence of 
infection was detected in resistant (C3H/He) mice after 9
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months of infection. Marked differences in the number of 
hepatic granulomas that developed in the two strains of 
mice were also observed, which has previously been 
documented (2.16).
Intestinal lesions were not detected in any of the 
infected mice. Mesenteric lymph node lesions precede the 
development of intestinal lesions in ruminants 
experimentally infected with Mycobacterium paratuberculosis 
(2.24). The progressive nature of the mesenteric lymph 
node lesions in the C57BL/6 mice suggested that intestinal 
lesions may eventually have developed had the infection 
period been extended. The incubation period of the natural 
disease ranges from several months to years (2.1), and the 
lack of intestinal lesions in these mice is probably due to 
the termination of the experiment at 9 months. Previous 
reports have shown that, given enough time, intestinal 
lesions eventually occur in susceptible mice (2.3,2.19).
Although a marked reduction in bacterial numbers was 
observed in Bcgr mice, complete bacterial clearance did not 
occur in any of the mice over the 9-month course of 
infection. It is uncertain as to whether bacterial 
clearance would have occurred in the resistant strain had 
the duration of the experiment been extended. Since all 
detectable lesions due to the infection had resolved in 
this strain by 9 months pi, it is possible that the 
bacteria would have eventually been cleared as well.
The results confirm that resistance to M. 
paratuberculosis. like other mycobacterial infections, is 
associated with the Beg gene, and that bacterial 
proliferation occurs in a susceptible mouse strain 
(C57BL/6) over a protracted (9 month) course of infection. 
Furthermore, progressive lesions resembling those of the 
natural disease in ruminants develop in these mice over the 
course of the infection.
These results suggest that genetically susceptible 
(Bcgr8) strains of mice may be used as an appropriate 
laboratory model for studying the entry, development of 
lesions, and other aspects of the pathogenesis of Johne's 
disease. However, only two strains of mice were examined 
in this study. Additional research is needed to determine 
whether all Beg8 mice may be used as a model of Johne's 
disease.
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CHAPTER 3. HISTOPATHOLOGY OF C57BL/6 MICE ORALLY INFECTED 
WITH MYCOBACTERIUM PARATUBERCULOSIS; LESIONS IN 
SUSCEPTIBLE MICE RESEMBLE THOSE IN RUMINANTS
Introduction
Paratuberculosis (Johne's disease) is a chronic, 
granulomatous, intestinal disease of ruminants caused by 
the acid-fast bacterium Mycobacterium paratuberculosis. 
Clinically, the disease is characterized by progressive 
weight loss and intractable diarrhea (3.1). Ruminants are 
infected at a young age, but several months to years may 
elapse before clinical signs occur (3.1). The disease 
occurs throughout the world and is particularly prevalent 
in domestic livestock (3.1). Estimates of the prevalence 
of paratuberculosis in the United States range from 3-17% 
in culled dairy cattle (3.2).
The lack of a suitable laboratory animal model for 
paratuberculosis has hampered research into the immunology 
and pathogenesis of this disease. Rabbits were the first 
laboratory animals shown to develop classical lesions of 
Johne's disease (3.3,3.4). Thickening and corrugation of 
the intestinal mucosa due to infiltration of epithelioid 
cells filled with acid-fast bacilli were observed in 25% to 
45% of rabbits within 3 to 18 months postinoculation 
(3. 3, 3.4). Unfortunately, other attempts to inoculate 
rabbits often failed, suggesting that rabbits were 
resistant to infection (3.5,3.6 ). This inconsistency may 
have been due to variations in the strains of rabbits
72
73
and/or bacilli used. It is now known that resistance to 
mycobacterial diseases in rabbits is under genetic control, 
and rabbits may be selectively inbred for their 
susceptibility or resistance to these infections (3.7). 
Since the discovery of this genetic association followed 
early paratuberculosis experiments with rabbits, it is 
likely that unsuccessful attempts were due to the 
inadvertent use of genetically resistant rabbits.
More recently, it has been shown that New Zealand 
white rabbits may be orally infected with Mycobacterium 
paratuberculosis. resulting in granulomatous intestinal 
lesions resembling those of the natural disease in 
ruminants (3.8). Intestinal lesions resembling 
paratuberculosis have also been described in a wild rabbit, 
suggesting that at least some rabbits may be naturally 
susceptible to the disease (3.9). Unfortunately, the lack 
of commercially available immunologic reagents in the 
rabbit make it difficult to study the immunology of 
paratuberculosis in this species.
Information on the susceptibility of mice to M. 
paratuberculosis is confusing and often conflicting (3.2- 
3,3.5-6,3.10). As in the rabbit, much of this confusion 
may be explained by the variable susceptibility of 
different mouse strains to mycobacterial infections 
(3.7,3.11-12). It is now known that resistance to 
mycobacterial infections in mice, like rabbits, is
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associated with the Beg gene (3.7,3.11,3.12). Previous 
failures to infect mice with M. paratuberculosis may have 
been due to the inadvertent use of genotypically resistant 
mice.
The comparative susceptibility of C57, CBA, and Swiss 
mice to an intraperitoneal infection with M. 
paratuberculosis has been reported (3.13). These 
experiments showed that C57 were more susceptible to 
infection, with Swiss mice being less so, and CBA being 
relatively resistant. Later experiments, in contrast, 
failed to demonstrate successful infection of C57 mice 
using an oral route of inoculation (3.14). This might be 
explained by the use of genetically undefined mice. It is 
now known, for example, that the inbred mouse strains 
designated C57BL/6 and C57BL/10 are Beg susceptible (Beg*) , 
yet C57BR and C57L are Beg resistant (Beg1) (3.15) . In 
addition, the duration of the infection in question was 
terminated at 9 months, and more importantly, the 
mesenteric lymph nodes, which proved to be of particular 
importance in the present studies, were not examined 
(3.14),.
More recent studies indicate that murine 
susceptibility to M. paratuberculosis. like other 
mycobacterial diseases, is also associated with the Beg 
gene (3.11). A correlation was shown between the Beg 
genotype and susceptibility to paratuberculosis infection
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as determined by comparative hepatic granuloma counts 50 
days after an intravenous infection with M. 
paratuberculosis (3.11). Although the numbers of viable 
bacteria were not determined, this study did indicate that 
early resistance to paratuberculosis, like other 
mycobacterial diseases, is associated with the Beg gene 
(3.11). The study was terminated at 50 days p.i., and the 
gut associated lymphoid tissues (GALT) were not examined, 
and therefore no comparisons to the natural disease were 
made.
The objective of this experiment was to determine 
whether a Begs strain of mice (C57BL/6N) could be 
successfully infected with M. paratuberculosis using an 
oral route of administration. Mice were inoculated via 
gastric gavage with 3 X 10n CFU of Mycobacterium 
paratuberculosis strain 19698 suspended in cream. The GALT 
and other tissues were histologically evaluated for the 
presence of lesions and acid-fast bacteria after 
postinoculation intervals of 7,8,9, and 11 months.
Materials and Methods
Mice
All mice used in the experiments were bred from a 
C57BL/6N breeder colony originally obtained from Harlan 
Sprague Dawley Inc., Indianapolis, IN, and bred at the 
AAALAC accredited, Louisiana State University, Division of 
Laboratory Animal Medicine Vivarium. Mice were housed in
polyprdpylene rodent boxes ("shoebox" cages) with 
stainless-steel wire tops, on heat-treated, aspen-chip 
bedding (Sani-Chips, P.J. Murphy Forest Products Corp., 
Montville NJ). Animals were fed Purina Rodent Chow 5001 
(Purina Mills, Inc., St. Louis, MO) and water ad libitum, 
and maintained on a 12/12-hour light/dark cycle. All mice 
were infected at 4 weeks of age and then weaned.
Uninfected control mice were housed in separate cages using 
identical husbandry conditions.
Organism and Preparation of Inoculum
Mycobacterium paratuberculosis ATCC strain 19698 was 
obtained from the USDA-ARS, National Animal Disease Center 
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth 
supplemented with Middlebrook OADC enrichment media (DIFCO 
labs, Detroit MI), 0.2% glycerol (Sigma, St. Louis, MO), 
and 2 mg/liter Mycobactin J (Allied Laboratories, Glenwood 
springs, CO). Broth cultures were incubated at 37°C for 3- 
5 months and bacteria were harvested by centrifugation (10 
minutes at 2000g), washed 3X in phosphate-buffered saline 
(PBS), sonicated for 10 seconds at 40W (Heat Systems- 
Ultrasonics Inc., Plainview, N.Y.) to reduce clumping, and 
adjusted to 3 X 1011 paratuberculosis per dose as 
determined by a McFarlands nephelometer standard. Each 
dose was suspended in 0.3ml of cream and administered 
orally by gavaging with a ball-tipped needle. The number 
of viable bacteria per inoculum was later verified by
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plating serial dilutions on Middlebrook 7H10 agar 
supplemented with OADC and Mycobactin J.
Histologic Examinations
Animals were killed by cervical dislocation at 7, 8 ,
9, and 11 months after infection. Liver, spleen, duodenum, 
jejunum, ileocecal valve, colon, and mesenteric lymph nodes 
were fixed in neutral-buffered 10% formalin. At least one 
cross-section of liver (taken from the widest part of the 
left lobe), spleen, and at least one centimeter of each 
intestinal segment (duodenum, jejunum, ileum, and colon) 
were examined histologically from each mouse. A few 
mesenteric lymph nodes were lost during processing and 
therefore not examined. Tissues were routinely paraffin 
embedded and 5jum sections were stained with H&E and Ziehl- 
Neelsen acid-fast stains, and examined by light microscopy.
Immunohistochemical techniques were applied to tissue 
sections containing acid-fast bacteria. Formalin-fixed, 
paraffin-embedded tissues were sectioned and stained by the 
amino-ethylcarbazole (AEC) method using using rabbit anti- 
Mvcobacterium paratuberculosis polyclonal antibody (Dako 
Inc., Carpinteria, CA).
Results
A total of 18 out of 31 (58%) orally inoculated mice 
were found to have demonstrable acid-fast bacteria in their 
tissues. The infection was most often limited to the 
mesenteric lymph nodes. Of the 26 mesenteric lymph nodes
examined, 17 (65%) were found to be infected (Table 3.1). 
Acid-fast bacteria were found in the 3 of the livers and 3 
of the spleens (in 5 mice). Immunohistochemical staining 
of infected tissue sections with rabbit anti-Mvcobacterium 
paratuberculosis antibody confirmed that the organisms were 
mycobacteria. No lesions or acid-fast bacteria were 
present in the intestines of any of the mice.
The severity of the lesions in the infected mesenteric 
lymph nodes varied, but multinucleated giant cell formation 
was a consistent finding. The most severely affected nodes 
were observed in those mice that had been inoculated for 11 
months (Fig. 3.1). In these nodes, the normal follicular 
architecture was effaced by pale, swollen macrophages and 
multinucleated giant cells containing numerous acid-fast 
bacteria (Fig. 3.1). A few lymph nodes had moderate 
infiltrations of neutrophils associated with the bacteria. 
Liver lesions consisted of microgranulomas comprised of 
small, periportal clusters of infected macrophages 
containing mycobacteria, surrounded by a few lymphocytes 
and neutrophils. Larger granulomas consisting 
predominantly of lymphocytes and fewer numbers of 
macrophages were often present around portal triads, but no 
acid-fast bacteria could be demonstrated in these. No 
acid-fast bacilli or related lesions were detected in the 
control mice.
Table 3.1. Results of histological examinations of C57BL/6 mice orally infected with 
Mycobacterium paratuberculosis.
P.I. 
INTERVAL8
NUMBER 
OF MICE 
EXAMINED
PRESENCE OF LESIONS AND 
ACID FAST BACTERIA
MESENTERIC 
LYMPH NODE
SPLEEN LIVER INTEST
11 MONTHS 6 4 (n=4)* 1 1 0
9 MONTHS 4 1 (n=2 )* 1 1 0
8 MONTHS 12 7 0 0 0
7 MONTHS 9 6 1 1 0
a Postinoculation interval following an oral infection with Mycobacterium
paratuberculosis.
* Some mesenteric lymph nodes were lost in process and therefore not examined.
Figure 3.1. Mesenteric lymph node of a C57BL/6 mouse 
eleven months after an oral infection with Mycobacterium 
paratuberculosis (A). Note the extensive infiltration of 
macrophages (arrows) . H&E stain, bar = lOOjxm. .
B: Higher magnification of the same lymph node 
demonstrating that the macrophages are engorged with acid- 
fast bacilli. Ziel Neelsens acid-fast stain.
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Discussion
Research into the immunology and pathogenesis of 
ruminant paratuberculosis has been slow due to the lack of 
an acceptable laboratory animal model for the disease. 
Several attempts to inoculate mice and other laboratory 
animals with Mycobacterium paratuberculosis were made in 
the first half of this century, (3.3-4,3.5-6, 3.10,3.16), 
but the results of these studies varied and were often 
contradictory. Since these studies were performed, 
advances have been made in our understanding of the genetic 
susceptibility to mycobacterial infections. This may 
explain some of the previous failures to experimentally 
inoculate laboratory animals with mycobacteria and certain 
other intracellular pathogens (3.7, 3.12, 3.15). The 
selection and use of animal strains of a specific, 
susceptible genotype (Bcgs) is required to reproduce the 
typical lesions and progressive infections associated with 
mycobacterial diseases (3.7, 3.11, 3.12).
In contrast to previous reports (3.14), this 
experiment documents a successful infection rate (over 58%) 
of C57BL/6 mice with a commonly available strain of M. 
paratuberculosis using an oral route of administration.
The actual number of infected animals in this study may 
have been underestimated due to the methods employed and 
the termination of the experiment at 11 months. Many of 
the mesenteric lymph nodes had limited, focal infections,
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suggesting that some infected animals may have been missed. 
Others may have been missed if bacteria had not yet 
multiplied to sufficient numbers for detection. The 
incubation period of the natural disease ranges from 
several months to years (3.1) and this may also be the case 
in murine infections.
An important finding in this study is the observation 
that almost all of the lesions and detectable mycobacteria 
were in the mesenteric lymph nodes. Furthermore, the 
severity of the lesions correlated with the duration of 
infection. Since intestinal lesions were not found in any 
of these mice, this suggests that the organisms replicate 
in the mesenteric lymph nodes before proliferating in the 
intestines. Mesenteric lymph node lesions also precede 
intestinal lesions in ruminants with paratuberculosis 
(3.17). Although M^ . paratuberculosis initially enters 
through the intestinal epithelium (3.18), the infection 
may require an extended incubation in the mesenteric lymph 
nodes before proliferating in the intestinal tract.
Failure to examine the mesenteric lymph nodes may have 
prevented the detection of oral infections of mice in 
previous studies (3.14).
This study indicates that certain genetically 
susceptible strains of mice may serve as useful models in 
studying the entry, immunology, and pathogenesis of 
paratuberculosis. Granulomatous lesions containing acid-
fast bacteria, similar to those of the natural disease of 
ruminants, developed in mice following an oral infection 
with Mycobacterium paratuberculosis. Although it is 
possible that these infections may have been self-limiting, 
this seems unlikely since the severity of the lesions 
increased with the duration of the experiment. In 
addition, more acid-fast bacteria were detected in the 
lesions of mice infected for 11 months, compared to those 
infected for shorter time periods, which suggested that the 
organisms were viable and proliferating. Had the 
experimental interval been extended, the infection may have 
been demonstrated in the intestines, as occurs in the 
natural disease of ruminants.
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CHAPTER 4. COMPARISON OF NON-SPECIFIC MACROPHAGE 
ACTIVATION BETWEEN C57BL/6 AND C3H/He MICE INFECTED 
WITH MYCOBACTERIUM PARATUBERCULOSIS USING A 
LISTERIA SP. CHALLENGE ASSAY
Introduction
Paratuberculosis (Johne's disease) is a chronic, 
granulomatous, intestinal disease of ruminants caused by 
the acid-fast bacterium Mycobacterium paratuberculosis 
(4.1-3). Clinically, the disease is characterized by 
progressive weight loss and intractable diarrhea (4.1-3). 
Ruminants are infected at a young age, but several months 
to years may elapse before clinical signs occur (4.2). The 
disease occurs throughout the world and is particularly 
prevalent in domestic livestock (4.2). Estimates of the 
prevalence of paratuberculosis in the United States range 
from 3-17% in culled dairy cattle (4.4).
The apparent lack of a suitable laboratory animal 
model in which to study paratuberculosis previously 
hampered research into the immunology of the disease. 
Currently, little is known about the immune response to 
infection with M. paratuberculosis. compared to other 
mycobacterial infections such as tuberculosis and leprosy. 
Recently, however, mice having the susceptible allele of 
the Beg gene (Bcgs) have been shown to be susceptible to M. 
paratuberculosis infection (4.5, chapters 2 and 3). 
Susceptible mice develop progressive, granulomatous lesions 
resembling those of the natural infection in ruminants, and
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may be used as a model to study the immunology and 
pathogenesis of paratuberculosis (chapters 2 and 3).
The immunologic effects of Mycobacterium 
paratuberculosis infection in mice have not been thoroughly 
examined. It has been shown that the DTH response against 
sheep erythrocytes injected into the footpads of mice is 
suppressed following an intraperitoneal (i.p.) injection of 
non-viable M. paratuberculosis (4.6). This suggests that 
some degree of T cell-mediated immunosuppression is present 
in the skin. However, DTH responses are independent of CMI 
responses, and often one may be present without the other
(4.7). Thus, measurement of the DTH response may not be an 
adequate measure of the protective CMI response in an 
infected host.
The Listeria sp. challenge assay may be a more 
accurate measurement of the level of the host CMI response 
to infection (4.8-9). The ability of a host to kill the 
facultative intracellular parasite Listeria monocytogenes. 
is known to reflect the level of activation of the host 
mononuclear phagocytic (macrophage) compartment (4.8-10). 
Macrophage activation is induced by a wide variety of 
pathogens, and the measurement of the host response against 
listeria may therefore be used to quantitate this non­
specific resistance induced by entirely unrelated organisms 
(4.9). The listeria challenge assay has been widely used
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as a sensitive, in vivo measure of non-specific macrophage 
activation (4.8-10).
To determine whether infection with Mycobacterium 
paratuberculosis results in the activation or suppression 
of macrophages, and to determine whether there are 
detectable differences in the magnitude or timing of 
macrophage activation between a mycobacterial resistant 
versus susceptible strain of mouse, a listeria challenge 
assay was employed. Two strains of mice, differing in 
their mycobacterial susceptibility, were inoculated with 
Mycobacterium paratuberculosis and tested at various 
postinoculation (pi) intervals. Infected mice were then 
assayed for their ability to kill listeria in vivo.
Materials and Methods
Mice
Both the C3H/HeN and C57BL/6N mice used in this study 
were originally obtained from Harlan Sprague Dawley, Inc., 
Indianapolis, IN, and bred at the AAALAC accredited, 
Louisiana State University, Division of Laboratory Animal 
Medicine Vivarium. Mice were housed in polypropylene 
rodent boxes ("shoebox" cages) with stainless-steel wire 
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J. 
Murphy Forest Products Corp., Montville NJ). Animals were 
fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis, 
MO) and water ad libitum, and maintained on a 12/12-hour
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light/dark cycle. All mice used in the study were infected 
at 4-6 weeks of age.
Microrgani sms
Mycobacterium paratuberculosis ATCC strain 19698 was 
obtained from the USDA-ARS, National Animal Disease Center 
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth 
supplemented with Middlebrook OADC enrichment media (DIFCO 
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin 
J (Allied Laboratories, Glenwood springs, CO). Broth 
cultures were incubated at 37°C for 3-5 months and bacteria 
were harvested by centrifugation (2000g), washed 3X in 
phosphate-buffered saline (PBS), sonicated for 10 seconds 
at 4 0W (Heat Systems-Ultrasonics Inc., Plainview, N.Y.) to 
reduce clumping, and adjusted to 3 X 109 M. 
paratuberculosis per dose as determined by a McFarlands 
nephelometer standard. The number of viable bacteria per 
inoculum was later verified by plating serial dilutions on 
Middlebrook 7H10 agar supplemented with OADC and Mycobactin 
J. Mice were inoculated by the intraperitoneal route with 
1 X 109 bacteria suspended in 0.3ml sterile PBS.
A culture of Listeria monocytogenes was obtained from 
Dr. James Krahenbuhl of the Hansens Disease Center, Baton 
Rouge, LA. (11) . To increase the virulence, organisms were 
passaged through Balb/C mice by intravenous inoculation and 
recovery from the spleens 3 days later. Virulent isolates 
were then cultured in tryptic soy broth (TSB) for 18 hrs at
90
37°C. Cultures were centrifuged for 15 min at 1600 g and 
resuspended in TSB containing 20% glycerol. Aliquots of 
the concentrated inoculum were stored frozen at -80°C. 
Frozen aliquots were thawed and diluted with sterile PBS to 
prepare individual inoculation doses containing 5 X 10s 
bacteria suspended in 0.2 mis PBS. Bacterial counts of the 
inoculum were confirmed by plating serial dilutions on 
tryptic soy agar and counting colony forming units after 24 
hours of incubation at 37° in a humidified incubator. 
Listeria Challenge Assay
Both resistant (C3H/He) and susceptible (C57BL/6) mice 
were infected i.p. with 1 X 109 viable Mycobacterium 
paratuberculosis bacilli. The infections were timed so 
that the listeria assay could be simultaneously performed 
on groups of mice that had been infected with M. 
paratuberculosis at postinoculation intervals of 4, 8 , 10, 
15, 22, 30, and 36 days. Control mice were inoculated i.p. 
with 0.3 ml of sterile PBS 5 days before the start of the 
assay. Each postinoculation group consisted of at least 8 
mice. Only one strain of mice was used in some 
postinoculation intervals.
Both mycobacterial infected and control mice were then 
inoculated intravenously with 2 X 1 0s viable Listeria sp. 
via tail vein injection. After 24 hours, half of the mice 
(n>4) were killed by cervical dislocation and spleens were 
aseptically removed and stored in ice cold PBS. Spleens
were homogenized in 10 mis PBS using pestle-type tissue 
homogenizers (Thomas Scientific, Swedesboro, NJ) and serial 
dilutions were plated on tryptic soy agar (TSA) petri 
dishes. Plates were incubated for 24 hours at 37° in a 
humidified incubator and colony forming units (CFU) of 
listeria were then determined using a colony counter 
(Brunswick Scientific, New Jersey). The remainder of the 
mice were killed 48 hours after the listeria infection and 
CFU of listeria were determined from the spleens of these 
mice in the same manner. The 24 hour listeria assay was 
repeated, this time with fewer groups of mice infected at 
intervals of 5, 10, 15, and 30 days.
Results
The growth of listeria in the spleens of control and 
mycobacteria-infected mice is shown in figures 4.1-4.3.
Both C57BL/6 and C3H/Hen mice demonstrated markedly 
increased listeria killing ability following an 
intraperitoneal infection with Mycobacterium 
paratuberculosis. Although enhanced listeria killing was 
evident by 5 days after the mycobacterial infection, peak 
killing ability seemed to occur within ten days after the 
infection. Significant (P<0.05), logarithmic decreases in 
the number of listeria CFU isolated from the spleens were 
detected in all mice that had been inoculated 8 or more 
days prior with M. paratuberculosis (Appendix B). Although 
the results of experiment 1 suggested that C3H/He mice may
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Figure 4.1. Experiment no.l; 24 hr. growth of listeria in 
the spleens of mice infected at varying pi intervals with 
Mycobacterium paratuberculosis. Each point represents the 
mean CFU of at least 4 mice 24 hrs after listeria 
infection. Inoculum = 2 X 105 listeria given i.v. Error 
bars indicate the standard error of the mean.
93
48 h r L isteria  A ssa y
1e+8
♦ — C3H/He n ice  
* -  C57BL/6 mice
£ 1e+7 -
CL
o> 1e+6 -
u.
o> le+5 -
1e+4 -
4030 3515 20 250 5 10
Time after M. paratb. infection (days)
Figure 4.2. Experiment no. 1; 48hr. growth of listeria in 
the spleens of mice infected at varying postinoculation 
(p.i.) intervals with Mycobacterium paratuberculosis. Each 
point represents the mean CFU of at least 4 mice 48 hrs 
after listeria infection. Inoculum = 2 X 10s listeria given 
i.v. Error bars indicate the standard error of the mean.
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Figure 4.3. Experiment no. 2; 24 hr. growth of listeria in 
the spleens of mice infected at varying intervals with 
Mycobacterium paratuberculosis. Each point represents the 
mean CFU of at least 4 mice tested 24 hrs after listeria 
infection. Inoculum = 2 X 10s listeria given i.v. Error 
bars indicate the standard error of the mean.
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be inherently more adept at listeria killing (Figs. 4.1,
4.2), experiment 2 showed that this was not the case (Fig.
4.3). No statistically significant differences in the 
magnitude or timing of macrophage activation were observed 
between the two strains of mice.
Discussion
Resistance to mycobacterial infections is attributed 
to effective cell-mediated immunity in which lymphocyte- 
macrophage interactions predominate (4.12). This 
interaction usually leads to macrophage activation and 
bacterial inhibition or clearance. A correlation often 
exists between the spectrum of lesions produced in response 
to a particular pathogen and the host CMI status. In 
general, depressed CMI is present in patients with 
lepromatous leprosy and atypical (MAI complex) 
mycobacterial infections, while enhanced cell-mediated 
immunity is a characteristic of tuberculoid leprosy and M. 
tuberculosis infections (4.7,4.13-14). The granulomatous 
nature of the intestinal lesions produced by M. 
paratuberculosis infections in cattle more closely resemble 
those observed in lepromatous leprosy, suggesting that 
depressed CMI responses may be present in paratuberculosis 
as well (4.3). Furthermore, in advanced stages of bovine 
paratuberculosis, delayed-type hypersensitivity reactions 
and lymphocyte transformation responses to M. 
paratuberculosis antigens are often suppressed (4.2,4.15).
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A decreased capacity to produce interleukin-2 (IL-2) has 
also been observed in cattle chronically infected with M. 
paratuberculosis (4.15). This suggests that cattle 
chronically infected with M. paratuberculosis have 
defective or depressed CMI responses.
Since specific, inbred strains of mice have been shown 
to be susceptible to Mycobacterium paratuberculosis 
infections, it was hypothesized that differences in the 
levels of macrophage activation might be detected between a 
susceptible versus resistant strain of mice in response 
infection with M. paratuberculosis. The present study 
attempted to detect a difference in the level of macrophage 
activation between C3H/He (Bcgr) and C57BL/6 (Beg*) mice 
using a listeria challenge assay.
Marked non-specific macrophage activation was 
demonstrated in both Beg resistant and Beg susceptible 
strains of mice by 8 - 1 0 days after infection with a large 
i.p. dose of Mycobacterium paratuberculosis. Although it 
was previously shown that C57BL/6 mice are more susceptible 
to paratuberculosis than C3H/He mice (chapters 2 and 3), no 
innate differences in macrophage activation were detected 
between the two strains using the listeria challenge assay. 
Peak listeria killing ability for both mouse strains 
occurred between 10 and 15 days (Figures 4.1-4.3).
Although all pathogenic mycobacteria are intracellular 
pathogens with the capacity to grow inside phagocytic
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cells, the mechanism by which different mycobacterial 
species escape host microbicidal functions varies from one 
species to another (4.10,4.12). Variation in the 
resistance of mycobacteria to activated macrophages exists 
even among closely related species (4.10). Some 
organisms, such as M. tuberculosis are sensitive to the 
presence of activated macrophages, while some members of 
the Mycobacterium avium/intracellulare (MAI) complex are 
unaffected by activated macrophages (such as M. avium and 
M. kansasii) while still others (such as M. intracellulare) 
may actually grow better in the presence of activated 
macrophages (4.10).
This experiment demonstrates that in mice, macrophage 
activation, rather than macrophage suppression, results as 
a consequence of infection with a large dose of 
Mycobacterium paratuberculosis. Although markedly fewer 
numbers of viable Mycobacterium paratuberculosis organisms 
are isolated from the spleens of C3H/He mice compared to 
C57BL/6 mice within 10 days after infection (chapter 3), 
equal levels of macrophage activation (as determined by 
listeria killing ability) are present in both strains of 
mice in response to the mycobacterial infection. Although 
this does not prove that there are no differences in the 
level of macrophage activation between these two strains of 
mice, these results indicate that the mechanisms used by
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macrophages to kill listeria are ineffective against 
Mycobacterium paratuberculosis.
The mechanisms by which macrophages inhibit 
intracellular pathogens vary widely, even amongst closely 
related pathogens. Immunity to Mycobacterium tuberculosis 
for example, is mediated predominantly through the 
activation of CD4+ T cells (4.16), whereas the relative 
contribution of CD4+ T cells to protection against Listeria 
sp. seems to be rather small (4.17-18). Listeria sp. 
killing is mediated predominantly through the action of 
CD8+ and 7 $ TCR+ T cells (4.18-20). This is probably 
mediated through the generation of different macrophage- 
activating cytokines from specific T cell subsets. 
Stimulation of human and murine macrophages with certain 
cytokines such as TNF and GM-CSF is associated with anti- 
mycobacterial activity (4.21). In contrast, stimulation of 
macrophages with IFN-7 is associated with intracellular 
killing of listeria (4.21). The mechanisms by which CD8+ 
and 7 6 T cells stimulate macrophages to kill listeria are 
unknown, but probably involve the generation of reactive 
nitrogen intermediates (RNI) within phagocytes (4.22). The 
generation of RNI has been shown to be associated with 
listeria killing by murine (but not human) macrophages 
(4.21). Intracellular killing of Mycobacterium avium by 
cytokine-activated human or murine macrophages, in
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contrast, is not dependent upon the generation of reactive 
nitrogen intermediates (4.21).
It is still not known why some strains of mice (BcgT) 
inhibit mycobacterial replication, while other strains 
permit mycobacterial growth (Beg*) resulting in bacterial 
persistence and disease. Full elucidation of the 
mechanisms by which the Beg gene confers resistance may 
provide the key to controlling mycobacterial infections in 
the future.
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CHAPTER 5. COMPARATIVE ANALYSIS OF THE T CELL KINETICS OF
C57BL/6 AND C3H/He MICE IN RESPONSE TO INFECTION 
WITH MYCOBACTERIUM PARATUBERCULOSIS
Introduction
Paratuberculosis (Johne's disease) is a chronic, 
granulomatous, intestinal disease of ruminants caused by 
the acid-fast bacterium Mycobacterium paratuberculosis 
(5.1-3). Clinically, the disease is characterized by 
progressive weight loss and intractable diarrhea (5.1-3). 
Ruminants are infected at a young age, but several months 
to years may elapse before clinical signs occur (5.2). The 
disease occurs throughout the world and is particularly 
prevalent in domestic livestock (5.2). Estimates of the 
prevalence of paratuberculosis in the United States range 
from 3-17% in culled dairy cattle (5.4).
Immunity to paratuberculosis and other mycobacterial 
pathogens is believed to be cell-mediated, resulting from 
the complex interactions of T lymphocytes and macrophages 
(5.5-7). Immunity to Mycobacterium tuberculosis infection 
in mice, for example, is mediated primarily by a/3+ CD4+
CD8- T cells which activate macrophages, leading to 
bacterial inhibition or clearance (5.6 ,5.8 ).
Another population of CD3+ cells, referred to as yS T 
cells, have also been implicated in mycobacterial 
infections. These cells have been shown to increase in 
response to tuberculosis and certain leprosy infections 
(5.9-11). Experimental infections of mice have shown that
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7 6 T cells increase in the draining lymph nodes in response 
to infection with either M. bovis/BCG or M. tuberculosis
(5.8). Despite this association, the role that 7 5 T cells 
play in mycobacterial infections is still unknown.
Resistance to mycobacteria and other intracellular 
pathogens has been linked to a single gene referred to as 
the Beg gene (5.12-13). Although the product of this gene 
is not known, mice with the resistant allele of this gene 
{Beg') progressively eliminate mycobacteria, while those 
with the susceptible allele (Bcgs) allow bacterial 
proliferation and usually succumb to the disease (5.12-13). 
Investigations into the mechanisms of this resistance 
indicate that macrophages from susceptible mice are 
inferior in killing mycobacteria when compared to resistant 
mouse strains (5.14). However, macrophages from Beg8 mice 
can be activated to kill certain species of mycobacteria as 
efficiently as those from Bcgr mice when stimulated by 
cytokines (5.14). This suggests that the mechanism of 
resistance to mycobacteria may be at the T cell level 
rather than the macrophage.
Although much research has been performed with 
mycobacterial pathogens of humans, comparatively little is 
known about the T cell kinetics of infection with 
Mycobacterium paratuberculosis. To evaluate the kinetics of 
the T cell responses of mice to infection with 
Mycobacterium paratuberculosis. both C3H/He and C57BL/6
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mice were infected and tested at various postinoculation 
(pi) intervals with an intraperitoneal dose of viable M. 
paratuberculosis. Lymphocytes were then harvested from the 
peritoneal exudate cells (PEC), spleen, mesenteric lymph 
nodes (MLN), intestinal epithelium, lamina propria, and 
Peyer's patches from all mice.
Lymphocytes from all organs were analyzed for T cell 
subsets by labelling with a variety of monoclonal 
antibodies to detect changes in the proportions of T cell 
subsets and cell activation markers in response to 
infection.
To determine whether there were age-related 
differences in the response to infection, the experiment 
was repeated using aged mice (retired breeders). Only the 
peritoneal exudate cells were examined in the repeat 
experiment.
Materials and Methods
Microorganisms
Mycobacterium paratuberculosis ATCC strain 19698 was 
obtained from the USDA-ARS, National Animal Disease Center 
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth 
supplemented with Middlebrook OADC enrichment media (DIFCO 
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin 
J (Allied Laboratories, Glenwood springs, CO). Broth 
cultures were incubated at 37°C for 3-5 months and bacteria 
were harvested by centrifugation (2000g), washed 3X in
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phosphate-buffered saline (PBS), sonicated for 10 seconds 
at 40W (Heat-Systems Ultrasonics Inc., Plainview N.Y.) to 
reduce clumping, and adjusted to 3 X 109 M. 
paratuberculosis per dose as determined by McFarlands 
standards. The number of viable bacteria per inoculum was 
later verified by plating serial dilutions on Middlebrook 
7H10 agar supplemented with OADC and Mycobactin J. Mice 
were inoculated by the intraperitoneal route with 1 X 109 
bacteria suspended in 0.3ml PBS.
Mice
Both the C3H/HeN and C57BL/6N mice used in this study 
were originally obtained from Harlan Sprague Dawley, Inc., 
Indianapolis, IN, and bred at the AAALAC accredited 
Louisiana State University, Division of Laboratory Animal 
Medicine Vivarium. Mice were housed in polypropylene 
rodent boxes ("shoebox" cages) with stainless-steel wire 
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J. 
Murphy Forest Products Corp., Montville NJ). Animals were 
fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis, 
MO) and water ad libitum, and maintained on a 12/12-hour 
light/dark cycle. All mice used in the first study were 
infected at 4-6 weeks of age. In the second experiment, 
retired breeders were used, with ages ranging from 12 to 30 
months at the time of infection.
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Lymphocyte Isolation
Peritoneal exudate cells (PEC) were recovered from 
mice by lavaging the peritoneal cavity with approx. 10 ml 
of complete RPMI-1640 media containing 5% fetal bovine 
serum (RPMI-5, complete media). Cells were washed twice by 
centrifuging at 400g for 8 minutes with RPMI-5 and counted 
by trypan blue exclusion using a hemacytometer.
Splenocytes were collected by aseptically removing the 
spleen and placing them in sterile 15 ml centrifuge tubes 
containing 3ml of ice-cold, calcium and magnesium free 
phospho-buffered saline (PBS). Spleens were then placed 
upon sterile nylon mesh screens and minced with scissors. 
Using a sterile lOcc disposable syringe plunger, the pieces 
were gently pressed through the screen into a plastic petri 
dish. Cells were washed through the screen with several 
aliquots of PBS using a 5 ml pipette. The splenocytes were 
then transferred to 15 ml centrifuge tubes and washed IX 
with PBS (400g, 8 min.). Red blood cells were lysed by 
suspending the cell pellet in 4 mis of prewarmed NH4C1 
solution and incubated with shaking for 3 minutes in a 37°C 
water bath. The cells were then washed with complete RPMI- 
1640-5 and any large debris that quickly settled to the 
bottom of the cell suspension was removed by pipetting. 
Cells were suspended in RPMI-10 and placed on ice until 
staining.
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Mesenteric lymph node cells were harvested by 
carefully dissecting the nodes from the mesenteries and 
removing as much fat as possible. The nodes were then 
minced with razor blades and the fragments incubated in 15 
ml centrifuge tubes with 3ml of RPMI-5 containing 0.05 
mg/ml collagenase (SIGMA, type II). The fragments were then 
pressed through nylon mesh screens with a plunger. Cells 
were then washed 2X with PBS and resuspended in RPMI-10 and 
placed on ice until staining.
Intestinal epithelial lymphocytes (IEL) and lamina 
propria lymphocytes (LPL) were isolated from individual 
mice using modifications of a previously described protocol 
(5.15-16). The small intestines were bluntly dissected and 
removed from the abdomen and the mesenteries and blood 
vessels were carefully removed by sharp dissection. The 
lumens are flushed with 50 ml of cold PBS using a small 
piece of tubing attached to a 60 cc syringe. The Peyer's 
patches were then identified and removed with the aid of a 
dissecting microscope, and placed in 15 ml centrifuge tubes 
containing 2 ml of RPMI-5 until used. The intestines were 
then opened longitudinally with small scissors and cut 
into 1 cm long pieces. These were transferred to 125 ml 
Erlenmeyer flasks and washed 3X by swirling in PBS and 
discarding the supernatant fluid. The fragments were then 
suspended in 25 ml of Hanks balanced salt solution (HBSS) 
(Gibco) containing 104 M EDTA (SIGMA). The intestines were
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then incubated at room temperature for 30 minute intervals, 
while slowly stirring with a magnetic stir bar. At the end 
of each 3 0 minute interval, the cloudy supernatant fluid 
(containing cells) was transferred to 50ml centrifuge tubes 
and fresh HBSS/EDTA was added to the intestinal pieces.
This process was repeated at least three times or until the 
supernatant fluid was no longer cloudy after incubation. 
Histologic examination of some of the remaining intestinal 
tissue fragments was performed to confirm that the 
epithelium had been removed and the lamina propria was 
still intact. The supernatant fluid was then passed through 
60-ml syringe columns containing loosely packed glass wool 
to remove dead cells and tissue debris. To obtain the 
lymphocytes, discontinuous density gradients were prepared 
using Percoll (Sigma). To prepare the gradients, an 
isotonic preparation of Percoll was first made by mixing 
one part of a 10X solution of PBS with nine parts Percoll. 
This preparation was then diluted to 35% v/v and 60% v/v 
with RPMI-5. Gradients were prepared by underlayering 2 ml 
of the 35% solution with 2 ml of 60% Percoll. The 
epithelial cells were then suspended in 3-4 ml of RPMI-5 
and layered onto the top of the gradient and centrifuged at 
2000 rpm for 20 minutes (800g). The interface between the 
35% and 60% gradients which contained the lymphocytes was 
then collected by pipetting. Approximately 1-2 X 106
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cells/mouse were collected from these gradients. The IELs 
were suspended in RPMI-10 on ice until analyzed.
To collect lamina propria lymphocytes, the intestinal 
pieces remaining from the IEL isolation procedures were 
incubated in 25 ml of RPMI-5 containing 0.05 mg/ml 
collagenase in a 37°C water bath with vigorous shaking for 
three consecutive 30 minute intervals. Following each 
interval, the intestinal pieces were vigorously pipetted up 
and down at least 20 times with a 5 ml pipette. At the end 
of the third incubation, the pieces had usually dissociated 
into small fragments. To remove the tissue debris and dead 
cells, the resulting suspension was passed over a 60cc 
syringe column containing loosely packed glass wool. To 
enrich the lymphocyte population, the cell suspension was 
centrifuged over a 3 5%/60% Percoll density gradient as 
described for isolation of IELs.
Peyer's patches were pooled from each group of mice 
and pressed through nylon mesh screens with a lOcc syringe 
plunger. The cells were washed 2X with PBS and resuspended 
in RPMI-10 until use.
Detection of T Cell Subsets
Cells from the above preparations were adjusted to 2 X 
106 cells/ml and 50 ji 1 aliquots were incubated with 
appropriately diluted FITC or PE conjugated, anti-mouse 
antibodies against CD3, a/3 TCR, TCR, CD4, CD8a
(Pharmingen, San Diego, CA) on ice for 30 minutes. For
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other experiments, identical batches of cells were labelled 
with markers of cell activation (see chapter 6). Cells were 
then washed with PBS and fixed in 1% paraformaldehyde 
overnight.
Samples were analyzed on a FACScan flow cytometer 
(Becton Dickinson, San Jose, CA) equipped with a 15mW air- 
cooled 488 nm argon-ion laser. The green fluorescence or 
FITC staining was collected with a 530/30 nm band pass 
filter. Detection of phycoerythrin emission was filtered 
through a 585/42 nm band pass filter. Electronic 
compensation was used among the fluorescence channels to 
remove residual spectral overlap. A minimum of 10,000 
events were collected on samples taken from the various 
tissues. All samples were acquired in the list mode manner 
on a Hewlett Packard 340 computer system (San Diego, CA) 
and the data was analyzed using Lysys II software package 
(Becton Dickinson, San Jose, CA).
A gated lymphocyte population was derived from a 
bivariate histogram display of forward and side scatter, 
thereby excluding macrophages and other nonlymphoid cell 
types. The gated lymphocytes were subsequently plotted on 
a dot display illustrating log green fluorescence versus 
log red fluorescence and immunofluorescence data for the T- 
cell populations were quantitated. Gates were set at 20 
and 100 for CD3, yS TCR, CD4 and CD8 analysis.
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Percentages of lymphocytes were determined rather than 
the actual number for two reasons. First, the actual 
number of lymphocytes collected from the GALT would be 
prone to error since the collection methods used result in 
the collection of only a fraction of the total lymphocyte 
population. Experimental deviation between samples in 
these tissues could significantly alter the results and 
provide erroneous data. Secondly, since T cells exert 
their effects in a paracrine or autocrine manner, it was 
believed that reporting the percentages of T cells in 
relation to other cell populations are more important than 
their actual number.
Statistical Analysis
Data was analyzed using a comparative analysis of 
variance using Tukeys studentized range test. For 
comparisons between each group, least square means were 
compared using a pairwise t test. Groups of mice of 
different postinoculation intervals were compared within 
strains, and those of the same postinoculation intervals 
were compared between strains.
Results
Peritoneal Cells of Infected Weanlings
Within 5 days after M. paratuberculosis infection, 
marked increases in lymphocytes and macrophages were 
detected in the peritoneal cavity (Fig. 5.1). Peritoneal 
lymphocyte populations continued to increase throughout the
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study. Dual staining of cells with anti-CD3 antibodies 
revealed a steady, continual increase in the proportion of 
CD3+ cells (T cells) in the first 30 days (Fig. 5.2). 
Although higher levels of CD4+ cells were detected in both 
control and infected C3H/He mice compared to the C57BL/6 
strain, the proportion of CD4+ cells (expressed as a 
percentage of the total CD3+ population) dropped in 
response to infection in both strains of mice (Fig. 5.3).
The predominant cells responding to the initial 
infection in the peritoneum were either CD8+ and/or yS T 
cells (Figs. 5.4-5.6). No CD8+,y<S+ (double-positive) cells 
were observed in the peritoneum of any mice (Fig. 5.6). 
Although increases in CD8+ and yS T cells were noted in 
both strains, significantly higher levels of these cell 
types responded to the infection in the C57BL/6 strain 
whereas more CD4+ cells were present in the C3H/He mice 
(Figs. 5.3-5.5).
Peritoneal Cells of Mice Infected as Adults
The T cell responses of aged mice (retired breeders) 
were similar to those infected as weanlings (Addendix D) 
Marked increases in CD3+ cells were detected by 3 days p.i. 
The majority of responding cells were yS TCR+ T cells. 
Five-fold increases in the numbers of yS T cells were 
present in both mouse strains within 5 days after 
infection. Uninfected C3H/He mice had markedly higher 
proportions of CD4+ T cells than C57BL/6 but the
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Figure 5.1. Dot plot of forward vs side scatter analysis 
of the peritoneal cell response to Mycobacterium 
paratuberculosis infection in C57BL/6 mice. A: Represents 
the resident peritoneal cell population of an uninfected 
control C3H/He mouse. B: Represents the peritoneal exudate 
cell population of a C3H/He mouse 5 days after M- Paratb. 
infection. Note the abundant population of lymphocytes (L) 
and larger, less granular macrophages (M).
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Figure 5.2. Comparison of the peritoneal CD3+ T cell 
response of C3H/He and C57BL/6 mice to an intraperitoneal 
infection with 1 X 109 viable Mycobacterium 
paratuberculosis bacilli. Note the steady increase in the 
proportion of CD3+ cells in response to the infection over 
time. Error bars indicate the standard error of the mean.
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Figure 5.3. Comparison of the response of CD4+ T cells in 
the peritoneum of C57BL/6 and C3H/He mice to infection with 
Mycobacterium oaratuberculosis♦ Higher proportions of CD4+
T cells are present in C3H/He mice both in uninfected 
controls (day 0) and early in the infection. Error bars 
indicate the standard error of the mean.
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Figure 5.4. Comparison of the response of CD8+ T cells in 
the peritoneum of C57BL/6 and C3H/He mice to infection with 
Mycobacterium paratuberculosis. Although marked increases 
of CD8+ cells respond to the infection in both strains of 
mice, higher proportions are present in C57BL/6 mice both 
in uninfected controls (day 0) and early in the infection. 
Error bars indicate the standard error of the mean.
117
Peritoneal Gamma/Delta T cell Response
l~ 1 C3H/He n ic e  
YZZZA C57BL/6 mice70 -
+
Q
O
O
v®0s 50 -
+
O
I-
w
40 -
| 30- 
I 2 0 '
a**
10 -
15d 30d
Postinoculation interval (d=days, mo=months)
5moContro
Figure 5.5. Comparison of the response of gamma/delta 
(yS) T cells in the peritoneum of C57BL/6 and C3H/He mice 
to infection with Mycobacterium oaratuberculosis. Marked 
increases of yS T cells are present in infected mice of 
both strains compared to controls. Error bars indicate 
standard error of the mean.
*10°
FLl-H^FITC --->
‘ 102 IP .........id**
CD3+
76+
B
8*
. ' V  •  *  *  •
"** ^  in .     * «v^SSSSSjBBKl^ }': ’
•* ’V.r/t' ’
*>.; *'*•*« .• A# ' *fe’. Vi-, * ^
v:Wpjap5fflsSt,^,.» * - ■£■'• \ *
• _ - r.1 /
. • •• - * <r7r.r—
‘. • '■•' *.J: >"'•■ '
• 7-^-.... J; . li*.< ’
.v .......,‘^.r i.. * ‘ ' » • . >;i, . r ,
nfe* ........ T5T
FL1-H\FITC --->
T5T T5T iff*
CD8+
Figure 5.6. Dot plot of the peritoneal cell response of a 
C3H/He mouse 30 days after an i.p. infection with 
Mycobacterium paratuberculosis. A: Most of the responding 
cells are both CD3+, 7 $+ T cells. B: Dual staining with 7 S 
and CD8+ antibodies shows that the cells are not double 
positive for these markers.
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proportions of these dropped in both strains in response to 
infection. Uninfected C57BL/6 mice had higher proportions 
of CD8+ cells but these also dropped in response to 
infection. No significant differences between the 
responses of young and aged mice were detected.
Spleen Cells
In both control and infected mice, the proportions of 
CD4+ cells were higher in resistant mice (C3H/Hen) while 
CD8+ cells were the predominant T cell in C57BL/6 mice 
(Fig. 5.7-5.8 ). No striking changes in the proportions of
T cell subsets were detected in the spleens of either
strain in response to infection. The total percentage of 
CD3+ cells dropped in some animals after infection, 
possible due to B cell infiltration or proliferation. 
Intraepithelial Lymphocytes
In both murine strains, the vast majority of the IEL 
population was CD3 + , 7 <5+, CD8+. Although 7 8 T cells were 
present in many other organs, the IEL's were the only 
compartment in which significant numbers of double positive 
CD8+, 7 $ TCR+ cells were observed.
Changes in response to infection with M. 
paratuberculosis infection were observed in the C3H/He
mice, consisting of significant increases in the number of
CD4+ cells within 15 days postinoculation. No other 
significant differences were observed amongst the IEL's of 
either strain.
120
Spleen CD4+ Cell Response
100 rz~1 C3H/He mice 
VZm C57BL/6 n ice
80 -
Q60 -
0 20 -
10d 15d 30d
Postinoculation interval (d=days, mo=months)
5moContro
Figure 5.7. Comparison of the CD4+ T cell response in the 
spleens of C3H/He and C57BL/6 mice in response to infection 
with Mycobacterium paratuberculosis. Note the higher 
percentage of CD4+ cells in the C3H/He strain. Error bars 
indicate the standard error of the mean.
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Figure 5.8. Comparison of the CD8+ T cell response in the 
spleens of C3H/He and C57BL/6 mice in response to infection 
with Mycobacterium paratuberculosis. Note the higher 
percentage of CD8+ T cells in the C57BL/6 strain. Error 
bars indicate the standard error of the mean.
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Lamina Propria Lymphocytes
The total proportion of CD3+ lymphocytes in the lamina 
propria significantly dropped in the C3H/He strain after 
infection, suggesting that a stronger B cell response may 
have developed in this strain. Significantly higher levels 
of CD4+ cells were present in the lamina propria of C3H/He 
mice compared to the C57BL/6 mice (Fig. 5.9). In both 
strains, the proportions of CD4+ cells initially dropped, 
but then rebounded, and by 30 days both strains had higher 
proportions of CD4+ LPL's than uninfected controls (Fig. 
5.9). The initial LPL cells responding to the infection 
were CD8+ and/or yS T cells in both mouse strains. Marked 
increases in CD8+ cells were detected in both strains by 3 
days postinoculation.
Peyers Patches
Since Peyer's patches were pooled in all groups, only 
trends over time are reported rather than statistically 
significant data. However, changes in the Peyer's patches 
were similar to those in other organs. Higher percentages 
of CD4+ cells were present in the C3H/He mice in response 
to infection while C57BL/6 mice had higher proportions of 
CD8+ and/or yS T cells (Appendix C).
Mesenteric Lymph Modes
Both strains of mice had a slight drop in the 
proportion of T lymphocytes (CD3+ cells) in response to
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Figure 5.9. Comparison of the CD4+ T cell response in the 
lamina propria of C3H/He and C57BL/6 mice in response to 
infection with Mycobacterium paratuberculosis. Note the 
higher percentage of CD4+ T cells in the C3H/He strain. 
Error bars indicate the standard error of the mean.
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infection. The proportion of T cells was consistently 
higher in C3H/He mice than C57BL/6 mice. Markedly higher 
proportions of CD4+ cells were present in the mesenteric 
lymph nodes of control and infected C3H/He mice compared to 
the C57BL/6 strain (Fig. 5.10). The average percentage of 
CD4+ mesenteric lymphocytes was approximately 70% in C3H/He 
mice while those of C57BL/6 mice averaged between 35% to 
49% (Fig. 5.10). These percentages remained relatively 
stable throughout the infection. The percentages of yS T 
cells were consistently higher in the C57BL/6 mice than in 
the C3H/He mice (Fig. 5.11). No other significant changes 
were detected amongst the mesenteric lymph node lymphocyte 
subsets in response to infection.
Discussion
Previous studies have demonstrated that mice with the 
Beg resistant allele (Beg1) inhibit the replication of 
mycobacteria and certain other intracellular pathogens, 
while murine strains with the Beg susceptible allele (Beg*) 
allow proliferation of the pathogens, often resulting in 
disease or death (5.12,5.17). The product of the Beg gene 
is not known and the mechanisms underlying this selective 
susceptibility to intracellular pathogens are not 
understood. Macrophages from both Beg* and Bcgr strains of 
mice have been demonstrated to have the same capacity to 
kill certain mycobacteria when they are activated by the 
appropriate cytokine signals (5.14). Macrophage activation
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Figure 5.10. Comparison of the CD4+ T cell response in the 
mesenteric lymph nodes of C3H/He and C57BL/6 mice in 
response to infection with Mycobacterium paratuberculosis. 
Note the higher proportions of CD4+ Cells in the C3H/He 
strain. Error bars indicate the standard error of the 
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is dependent upon cytokines, predominantly secreted by 
antigen-activated T cells (5.18-19). Although cytotoxic T 
cells may play a role in the resistance to mycobacterial 
infections, macrophage activation through T cell-derived 
cytokines is thought to be the major effector mechanism 
involved in controlling mycobacterial infections (5.20).
Specific T cell subsets produce different arrays of 
cytokines and CD4+ T cells have been classified into two 
major subsets, referred to as Thl and Th2, based upon the 
pattern of cytokines they secrete (5.21). The Thl-type 
cells produce IL-2 and 7 -IFN, which (in addition to having 
a variety of other immunologic effects) are particularly 
important in the activation of T cells and macrophages. 
Thus, CD4+ Thl-type T cells are important in the generation 
of a cell-mediated response required for resistance to 
mycobacterial infections (5.22). In contrast, Th2 cells 
produce IL-4, IL-5, IL-6 , and IL-10, which lead to the 
generation of a non-protective humoral immune response and 
down-regulation of the protective Thl response (5.21-21).
Other T cell subsets, including 7 5 T cells and CD8+ T 
cells have been implicated in the pathogenesis of 
mycobacterial infections. The significance of the role 
that CD8+ cells play in mycobacterial infections is 
uncertain, but they may be important in the destruction of 
infected cells and/or macrophage activation via the 
generation of IFN-7 (5.23-24). The function of 7 6 T is
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also uncertain but marked increases in the number and/or 
proportion of this T cell subset have been described in 
several types of mycobacterial infections (5.8-11).
Since mycobacterial immunity is dependent upon the 
generation of specific T cell subsets, a comparison of the 
T cell subsets responding to mycobacterial infections in 
resistant and susceptible animals may assist in 
understanding why certain hosts are susceptible while 
others are resistant.
Our experiments have demonstrated that Begr mice 
(C3H/Hen) have significantly higher proportions of CD4+ T 
cells in their lymphoid organs and compartments as compared 
to a Beg* mouse strain (C57BL/6). Resistance to M. 
paratuberculosis may therefore be dependent upon the 
elaboration of cytokines from this CD4+ subset, resulting 
in optimum macrophage activation and mycobacterial killing. 
A similar mechanism of resistance to M. tuberculosis has 
previously been demonstrated (5.6). Experimental 
depletions of CD4+ cells in mice have also been shown to 
result in the exacerbation of the severity of M. kansasii 
infections (5.23).
Susceptible mice (C57BL/6) were shown to have higher 
proportions of CD8+ and/or yS T cells than C3H/He mice.
Both mouse strains respond to an intraperitoneal infection 
with M. paratuberculosis with marked increases in yS T 
cells. No differences in the proportions of yS T cells
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were detected in mice infected at different ages. This 
suggests that while 7 S T cells may play a role in the early 
response to pathogens, they do not seem to be associated 
with long term mycobacterial resistance. The higher 
proportion of 7 <S T cells in the susceptible strain suggests 
that they may play a role in susceptibility to the 
infection.
The innate differences between Beg resistant and 
susceptible strains of mice could be directly related to 
the higher percentages of the CD4+ T cell subset in 
resistant strains. Additional studies using multiple 
strains of mice might reveal that all Bcgr strains have 
proportionally higher numbers of CD4+ cells that promote 
increased resistance to mycobacteria and other 
intracellular pathogens. It is also possible, however, 
that the prominence of CD4+ cells in resistant mice could 
be secondary to other effects of the Beg gene. Innate 
differences in macrophages or other immune cells between 
susceptible and resistant mice could be present, resulting 
in excess production or impairment of specific cytokines, 
which in turn, could lead to differences in the T cell
profiles in the two strains. Furthermore, macrophages from
Bcgr mice have been shown to be better at antigen
presentation than their Beg’ counterparts (5.25). Since T
cells are activated by appropriately presented antigens on 
the surface of macrophages, a defect in antigen
presentation also could result in either a lack or surplus 
of certain T cell subsets in susceptible mice. Clearly 
additional studies are needed to determine the mechanisms 
responsible for the resistance to mycobacterial infections.
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CHAPTER 6 . COMPARATIVE ANALYSIS OF CD25 and CD44 
EXPRESSION IN C57BL/6 AND C3H/He MICE INFECTED 
WITH MYCOBACTERIUM PARATUBERCULOSIS
Introduction
Mycobacterial immunity is dependent upon a strong 
cell-mediated immune response mediated by macrophages, 
which are in turn dependent upon helper T cell signals for 
proper activation (6.1-2). Humoral immunity does not seem 
to play a role in mycobacterial immunity, and may even be 
detrimental to the host in some instances (6.3-5).
Infection of mice with Mvcobacterium paratuberculosis 
results in distinct changes in the proportions of T cell 
subsets in many lymphoid organs (chapter 5). Resistant 
mice have higher proportions of CD4+ T cells, both in 
uninfected controls and in response to the infection, 
whereas susceptible strains (C57BL/6) mice have higher 
proportions of CD8+ and 7 S T cells (chapter 5). It was 
thus demonstrated that resistance to M. paratuberculosis is 
associated with increased proportions of CD4+ T cells 
("helper T cells") , and CD8+ and/or 7 S T cells are more 
likely associated with bacterial susceptibility.
Specific T cell subsets produce different arrays of 
cytokines (6 .6 ). CD4+ T cells have been classified into 
two major subsets, referred to as Thl and Th2, based upon 
the pattern of cytokines they secrete (6 .6 ). Thl cells 
produce IL-2 and 7 -IFN, which (in addition to having a 
variety of other immunologic effects) are particularly
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important in the activation of T cells and macrophages. 
Thus, Thl-type T cells are important in the generation of a 
cell-mediated response required for resistance to 
mycobacterial infections (6 .5,6 .7). In contrast, Th2 cells 
produce IL-4, IL-5, IL-6 , and IL-10, which lead to the 
generation of a humoral immune response and down-regulation 
of the protective Thl response (6 .6 ,6 .7). Although overlap 
exists between the two types, the predominant CD4+ T cell 
response to an infectious agent may either be a Thl type, 
resulting in maximum macrophage activation and a strong 
cell-mediated immune response, or it may be predominantly a 
Th2 type, resulting more of a humoral immune response and 
inhibition of the Thl type response (6 .4,6 .6 ).
The mechanisms leading to the predominance of one Th- 
type over the other are unknown, but a number of general 
factors have been found to lead the response toward one or 
the other. Some factors that are known to favor the 
generation of a Thl (protective) response include the 
presence of IL-2, IFN-7 , activated CD8+ cells, low antigen 
doses, intracellular pathogens, larger (phagocytosed) 
antigens, and the utilization of macrophages as the 
predominant antigen-presenting cell (6 .8 ). IL-12 also is a
potent stimulator of Thl responses (6.9). Infections with 
Listeria monocytogenes result in increased IL-12 production 
by macrophages, which may be a key component of the host 
resistance to intracellular pathogens (6.9). Factors that
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generate a Th2 response include the presence of IL-4, IL- 
10, IL-1, a lack of CD8+ cells, high antigen doses, smaller 
(pinocytosed) antigens, and the predominant use of B cells 
as antigen presenting cells (6 .8 ). IL-10 inhibits the
production of Thl cytokines in vitro and probably 
suppresses Thl responses in vivo as well (6.9).
In an attempt to answer whether there were detectable 
differences in levels of T cell activation and generation 
of protective Thl responses between mycobacteria- 
susceptible and resistant strains of mice, lymphocytes were 
harvested from a variety of lymphoid tissues and labelled 
with monoclonal antibodies against CD4, CD25 and CD44 
molecules. Dual staining of cells with CD4 and the 
activation markers was employed to determine whether CD4+ T 
cells were activated.
In addition, assays for the production of IL-2 and IL- 
4 were performed on supernatents of splenocytes and 
peritoneal cells infected with Mycobacterium 
paratuberculosis in vitro. Cells from both C3H/He and 
C57BL/6 mice were tested to determine whether there were 
detectable differences in the production of these Thl and 
Th2 type-specific cytokines in cells from Beg* and Bcgr mice 
in response to the infection. Cytokine assays were 
performed using a CTLL-2 cell detection system and an MTT 
colorimetric assay.
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The generation of a Thl response in response to an 
infection should result in the production of increased IL- 
2. The expression of the IL-2 receptor (CD25) is highly 
inducible in T cells by activation of the T cell antigen 
receptors (6.10). Thus, the activation of CD4+ T cells 
(and other T cells) should be detectable as an increase in 
the percentage of cells expressing CD25.
Expression of the cell membrane marker CD44 (Pgp-1) 
was also analyzed in response to infection. This marker is 
expressed on several types of leukocytes, and has been 
shown to be important in the recognition and/or adhesion of 
activated T cells to certain endothelial receptors 
important in transendothelial migration (6.11). Although 
CD44 supports binding of lymphocytes to high endothelial 
venules, its functions in T cell homing are still unclear 
(6.12). The expression of CD44 has been reported to 
increase in response to infection with some bacterial 
pathogens (6 .1 2 ) and has also been utilized as a means to 
identify memory T and B cells (6.13). Cell membrane 
expression of CD44 should therefore be increased if the 
responding lymphocytes were activated in response to 
infection with Mycobacterium paratuberculosis.
Materials and Methods
Microorganisms
Mycobacterium paratuberculosis ATCC strain 19698 was 
obtained from the USDA-ARS, National Animal Disease Center
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth 
supplemented with Middlebrook OADC enrichment media (DIFCO 
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin 
J (Allied Laboratories, Glenwood springs, CO). Broth 
cultures were incubated at 37°C for 3-5 months and bacteria 
were harvested by centrifugation (2000g), washed 3X in 
phospho-buffered saline (PBS), sonicated for 10 seconds at 
40W (Heat-Systems Ultrasonics Inc., Plainview N.Y.) to 
reduce clumping, and adjusted to 3 X 109 M. 
paratuberculosis per dose as determined by McFarlands 
standards. The number of viable bacteria per inoculum was 
later verified by plating serial dilutions on Middlebrook 
7H10 agar supplemented with OADC and Mycobactin J. Mice 
were inoculated by the intraperitoneal route with 1 X 109 
bacteria suspended in 0.3ml PBS.
Mice
Both the C3H/HeN and C57BL/6N mice used in this study 
were originally obtained from Harlan Sprague Dawley, Inc., 
Indianapolis, IN, and bred at the Louisiana State 
University, Division of Laboratory Animal Medicine 
Vivarium. Mice were housed in polypropylene rodent boxes 
("shoebox" cages) with stainless-steel wire tops, on heat- 
treated, aspen-chip bedding (Sani-Chips, P.J. Murphy Forest 
Products Corp., Montville NJ). Animals were fed Purina 
Rodent Chow 5001 (Purina Mills, Inc., St. Louis, MO) and 
water ad libitum, and maintained on a 1 2 /1 2-hour light/dark
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cycle. With the exception of the second peritoneal cell 
experiment which utilized retired breeders, all mice were 
infected at 4-6 weeks of age.
Lymphocyte Isolation for Plow Cytometric Analysis
Peritoneal exudate cells (PEC) were recovered from 
mice by lavaging the peritoneal cavity with approx. 10 ml 
of complete RPMI-1640 media containing 5% fetal bovine 
serum (RPMI-5, complete media). Cells were washed twice by 
centrifuging at 400g for 8 minutes with RPMI-5 and counted 
by trypan blue exclusion using a hemacytometer.
Splenocytes were collected by aseptically removing the 
spleen and placing them in sterile 15 ml centrifuge tubes 
containing 3ml of ice-cold, calcium and magnesium free 
phospho-buffered saline (PBS). Spleens were then placed 
upon sterile nylon mesh screens and minced with scissors. 
Using a sterile lOcc disposable syringe plunger, the pieces 
were gently pressed through the screen into a plastic petri 
dish. Cells were washed through the screen with several 
aliquots of PBS using a 5 ml pipette. The splenocytes were 
then transferred to 15 ml centrifuge tubes and washed IX 
with PBS (400g, 8 min.). Red blood cells were lysed by 
suspending the cell pellet in 4 mis of prewarmed NH4C1 
solution and incubated with shaking for 3 minutes in a 37°C 
water bath. The cells were then washed with complete RPMI- 
1640-5 and any large debris that quickly settled to the 
bottom of the cell suspension was removed by pipetting.
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Cells were suspended in RPMI-10 and placed on ice until 
staining.
Mesenteric lymph node cells were harvested by 
carefully dissecting the nodes from the mesenteries and 
removing as much fat as possible. The nodes were then 
minces with razor blades and the fragments incubated in 15 
ml centrifuge tubes with 3ml of RPMI-5 containing 0.05 
mg/ml collagenase (SIGMA, type II). The fragments were then 
pressed through nylon mesh screens with a plunger. Cells 
were then washed 2X with PBS and resuspended in RPMI-10 and 
placed on ice until staining.
Intestinal epithelial lymphocytes and lamina propria 
lymphocytes were isolated from individual mice using 
modifications of a previously described protocol (6.14-15). 
The small intestines were bluntly dissected and removed 
from the abdomen and the mesenteries and blood vessels were 
carefully removed by sharp dissection. The lumens are 
flushed with 50 ml of cold PBS using a small piece of 
tubing attached to a 60 cc syringe. The Peyer's patches 
were then identified and removed with the aid of a 
dissecting microscope, and placed in 15 ml centrifuge tubes 
containing 2 ml of RPMI-5 until used. The intestines were 
then opened longitudinally with small scissors and cut 
into 1 cm long pieces. These were transferred to 125 ml 
Erlenmeyer flasks and washed 3X by swirling in PBS and 
discarding the supernatant fluid. The fragments were then
suspended in 25 ml of Hanks balanced salt solution (HBSS) 
(Gibco) containing 10^ * M EDTA (Sigma) . The intestines were 
then incubated at room temperature for 30 minute intervals, 
while slowly stirring with a magnetic stir bar. At the end 
of each 30 minute interval, the cloudy supernatant fluid 
(containing cells) was transferred to 50ml centrifuge tubes 
and fresh HBSS/EDTA was added to the intestinal pieces.
This process was repeated at least three times or until the 
supernatant fluid was no longer cloudy after incubation. 
Histologic examination of some of the remaining intestinal 
tissue fragments was performed to confirm that the 
epithelium had been removed and the lamina propria was 
still intact. The supernatant fluid was then passed through 
60-ml syringe columns containing loosely packed glass wool 
to remove dead cells and tissue debris. To obtain the 
lymphocytes, discontinuous density gradients were prepared 
using Percoll (Sigma). To prepare the gradients, an 
isotonic preparation of Percoll was first made by mixing 
one part of a 10X solution of PBS with nine parts Percoll. 
This preparation was then diluted to 35% v/v and 60% v/v 
with RPMI-5. Gradients were prepared by underlayering 2 ml 
of the 3 5% solution with 2 ml of 60% Percoll. The 
epithelial cells were then suspended in 3-4 ml of RPMI-5 
and layered on the top of the gradient and centrifuged at 
2000 rpm for 20 minutes (800g). The interface between the 
35% and 60% gradients which contained the lymphocytes was
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then collected with a pipette. Approximately 1-2 X 106 
cells/mouse were collected from these gradients. The IELs 
were suspended in RPMI-10 on ice until used.
To collect lamina propria lymphocytes, the intestinal 
pieces remaining from the IEL isolation procedures were 
incubated in 25 ml of RPMI-5 containing 0.05 mg/ml 
collagenase in a 37°C water bath with vigorous shaking for 
three consecutive 30 minute intervals. Following each 
interval, the intestinal pieces were vigorously pipetted up 
and down at least 20 times with a 5 ml pipette. At the end 
of the third incubation, the pieces had usually dissociated 
into small fragments. To remove the tissue debris and dead 
cells, the resulting suspension was passed over a 60cc 
syringe column containing loosely packed glass wool. To 
enrich the lymphocyte population, the cell suspension was 
centrifuged over a 35%/60% Percoll density gradient as 
described for isolation of IELs.
Peyer's patches were pooled from each group of mice 
and pressed through nylon mesh screens with a lOcc syringe 
plunger. The cells were washed 2X with PBS and resuspended 
in RPMI-10 until use.
Detection of T Cell Activation Markers
Cells from the above organs were adjusted to 2 X 106 
cells/ml and 50 jul aliquots were incubated with 
appropriately diluted, FITC or PE conjugated, anti-mouse 
antibodies against CD4, CD25, and CD44 (Pharmingen, San
143
Diego, CA) on ice for 30 minutes. Cells were then washed 
with PBS and fixed in 1% paraformaldehyde overnight.
Samples were analyzed on a FACScan flow cytometer 
(Becton Dickinson, San Jose, CA) using standard techniques 
as described in detail in chapter 5. Gates were set at 25 
and 10 for analysis of CD44 and 16 and 35 for analysis of 
CD25 for all samples analyzed.
Statistical Analysis
Flow cytometry data was analyzed using a comparative 
analysis of variance using Tukeys studentized range test. 
Each infected group was compared to controls using a 
pairwise t test.
Cytokines and Reagents for In Vitro Studies
Recombinant murine IL-2 (rIL-2)(Genzyme, Cambridge,
MA) and recombinant murine IL-4 (rIL-4)(GIBCO BRL, 
Gaithersburg, MD) were reconstituted in PBS containing 1% 
FCS and stored at 4°C. Aliquots containing 1670 U/ml (0.67 
/ig/ml) of IL-2 and 1 X 105 U/ml (1.0 jug/ml) IL-4 were 
prepared from the reconstituted solution immediately prior 
to each experiment.
CTLL.2 Cell Line
The CTLL.2 cells were obtained from Dr. K. Smith of 
Dartmouth University, and maintained in RPMI-1640 media 
containing 1% sodium pyruvate, lOOmg/L ampicillin, lOOmg/L 
streptomycin, 25mM L-Glutamine, HEPES buffer, 2-ME, and 10% 
FCS. For use in experiments, CTLL-2 cells were harvested 2
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days after splitting and washed 2X with PBS and resuspended 
in complete RPMI containing 5% FCS. Less FCS was used in 
experiments to avoid protein precipitation reactions in the 
MTT assay.
Preparation of Infected Cell Culture Supernatents
Splenocytes and peritoneal cells were isolated from 
mice as described above. All cell samples were washed an 
additional 2X with PBS. For experiment #1, peritoneal 
cells were adjusted to 4 X 105 cells/ml and splenocytes 
were adjusted to 5 X 106 cells/ml. In the second 
experiment, only peritoneal cells were used. For each 
experiment, 500/il aliquots of each cell suspension were 
dispensed separately into 24-well, flat bottomed tissue 
culture plates (Corning, NY). Half of all wells were 
infected with 1 X 10s viable Mycobacterium paratuberculosis 
suspended in 150/xl complete RPMI-10 (500:1 and 40:1 
bacteria/cell for PEC's and Splenocytes respectively). An 
additional 150/jlI of complete RPMI-10 was added to control 
wells. All plates were then incubated for three days at 
37°C with 5% C02 in a water-jacketed incubator.
Following incubation, the fluid from all wells were 
aspirated and centrifuged at 3000rpm for 10 minutes to 
remove all cells, bacteria, and debris. These supernatents 
were decanted for use in the cytokine assays.
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Cytokine Assays
The IL-2/IL-4 detection assays were performed using 
CTLL.2 cells and the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide] color detection method using 
slight modifications of a previously described procedure
(6.16). Supernatents from test samples were serially 
diluted five-fold in 50/zl complete RPMI-5, (beginning with 
50% and ending with 0.01% final concentration) in 96 well, 
flat bottomed tissue culture plates (Costar, Cambridge,
MA) .
Cultures of CTLL.2 cells were harvested in active, 
log-phase growth, washed twice with PBS to remove residual 
IL-2, and resuspended in complete RPMI-5 at 1 X 106 
cells/ml and 50/il of this cell suspension (50,000 
cells/well) was added to each well of the 96-well plates. 
Due to the high number of CTLL.2 cells required for the MTT 
assay, only one repetition was performed in each test 
sample. For positive control wells, 20ng (5 X 103 U) of 
IL-4 and 67 ng (17 U) of IL-2 were added to the first 
wells, followed by wells containing serial, five-fold 
dilutions. To differentiate between IL-2 and IL-4 
activity, duplicate wells containing test samples, CTLL.2 
cells, and 0.01 mg anti-mouse IL-4 (Pharmingen, Sorrento, 
CA) or 0.01 mg anti-murine IL-2 (Pharmingen, Sorrento CA) 
were also prepared. The plates were then incubated for 24 
hrs at 37°C, 5% C02 in a humidified incubator.
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After 24 hrs of incubation, 10ju of 5mg/ml of filter 
sterilized MTT/PBS solution was added to each well, and the 
plates were incubated for an additional 24 hours. After 
this second incubation, 100/il of 0.04N HCL in isopropanol 
was added to each well. To completely lyse the cells and 
to eliminate the formation of crystals, the solution was 
vigorous pipetted 4-5 times. The plates were read by an 
automated microtiter plate reader (BioLinx 2.0, Dynatech 
Labs) using a dual-wavelength filter set at 570nm and 
63 0nm.
Results
Cell Surface Expression of CD2 5 and CD44
The results of the CD25 and CD44 expression are 
tabulated in Appendix D. Expression of CD25 was low in all 
samples tested but significant differences between the two 
mice were detected within the peritoneal exudate cells in 
response to infection (Figure 6.1). Expression of CD25 
decreased following infection with Mycobacterium 
paratuberculosis in the susceptible mice, while CD25 
expression increased in the resistant strain (C3H/Hen) in 
response to infection. This phenomenon was present in both 
mice that had been infected as weanlings and as adults.
Analysis of CD44 expression was difficult due to the 
lack of clear distinctions between positive and negative 
staining. Although fixed gate settings were used to 
analyze the data, the variation was high. On the whole,
expression of CD44 initially decreased following infection, 
probably due to an infiltration of naive cells lacking 
homing markers. Within 15 days postinoculation, the 
percentages of CD44+ cells increased in the mesenteric 
lymph nodes, peritoneal cavity, and the GALT in both 
strains of mice. Expression of CD44 was higher in the 
mesenteric lymph nodes of C57BL/6 mice. No significant 
differences between the strains were detected in other 
organs. The number of CD4+/CD44+ (double positive) cells 
also increased in the peritoneum, spleen, GALT, and 
mesenteric lymph nodes following infection, suggesting that 
some degree of activation was present in the responding 
cells these tissues.
Cytokine Assays
No significant IL-2 or IL-4 production was detected in 
any of the cell samples tested in the in vitro assays. No 
differences in CTLL.2 cell growth were detected between 
infected and uninfected murine cells. Wells containing the 
highest amounts of the test-sample supernatents actually 
had the lowest numbers of proliferating CTLL.2 cells 
(Tables 6.1 and 6.2). Control wells containing rIL-2 and 
IL-4 did show significant CTLL.2 proliferation which was 
measurable by the MTT colorimetric assay to the level of 
0.6 Units/ml of IL-2 and 40 Units/ml of IL-4 (Table 6.1). 
Wells containing CTLL.2 cells without exogenous cytokines 
failed to proliferate.
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Figure 6.1. Comparison of IL-2 receptor (CD25) expression 
of the peritoneal cells of young C3H/He and C57BL/6 mice in 
response to an intraperitoneal infection with Mycobacterium 
paratuberculosis.
Table 6.1. Results of the CTLL-2 assay using MTT colorimetric assay for the detection of 
IL-2 and IL-4 by murine cells infected with Mycobacterium paratuberculosis.
MOUSE CELL
OPTICAL DENSITY (O.D.) READINGS 
OF SAMPLE DILUTIONS:
CYTOKINE CONTROLS 
(O.D. READINGS)
STRAIN SAMPLE
50.0% 10.0% 2.0% 0.5% 0.01% ANTI-IL4 ANTI-IL2
C57BL/6
MICE
Spleen
(Infected) 0.410 0.426 0.433 0.456 ND 0.341 0.332
Spleen
(uninfected) 0.396 0.436 0.433 0.444 ND
0.431 0.405
PEC
(infected) 0.275 0.464 0.471 0.511 ND 0.346 0.321
PEC
(uninfected) 0.419 0.448 0.475 0.502 ND 0.399 0.259
C3H/He
MICE
Spleen
(infected) 0.399 0.413 0.443 0.476 ND 0.524 0.314
Spleen
(uninfected) 0.492 0.438 0.435 0.479 ND 0.533 0.155
PEC
(infected)
0.364 0.339 0.383 0.426 ND 0.329 0.301
PEC
(uninfected)
0.399 0.358 0.328 0.379 ND 0.370 0.264
CONTROLS IL-2 alone* 0.794 0.543 0.262 0.376 0.486 ND ND
IL-4 aloneb 0.664 0.485 0.228 0.230 0.230 ND ND
CTLL-2 only 0.267 0.230 0.257 0.229 0.229 ND ND
C3H PEC only 0.036 0.036 0.039 0.041 0.030 ND ND
a Five-fold serial dilutions of IL-2 containing 17 units m  the first well, 3.4 U in 
the second, etc.
Table 6.2. Results from the repeated assay for the detection of IL-2 and/or IL-4 from 
cells infected for 3 days with Mvcobacterium paratuberculosis. Assay was performed using 
CTLL-2 cells and an MTT colorimetric assay.
MOUSE
STRAIN
SAMPLE
PEC'S
SAMPLE DILUTION (O.D.)
ANTI IL2 
ADDED
ANTI IL4 
ADDED50% 1 0% 2 .0%
C57BL/6 INFECTED 0.341 0.380 0.414 0.290 0.269
CONTROL 0.330 0. 362 0.431 0.304 0.294
C3H/HE INFECTED 0.294 0.379 0.410 0.203 0.145
CONTROL 0.363 0.396 0.417 0.309 0.327
IL-2/CTLL CELLS ALONE 0.590 ND ND ND ND
IL-4/CTLL CELLS ALONE 0.388 ND ND ND ND
Results are expressed as optical density using an MTT colorimetric assay to detect 
proliferation of CTLL.2 cell.
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Discussion
Mice resistant to M. paratuberculosis infection 
(C3H/He) have markedly higher proportions of CD4+ cells, 
both initially and in response to infection as compared to 
a susceptible (C57BL/6) strain (chapter 5). Both mice 
respond to an intraperitoneal infection with marked 
increases in CD8+ and y6 T cells (chapter 5). This 
indicates that specific T cell subsets are recruited to an 
infection with Mycobacterium paratuberculosis. but says 
little of their state of activation or functional 
capabilities.
These results of this experiment show that CD44+ 
expression in most organs is initially decreased, probably 
as a result of the recruitment of naive T cells to the 
infection. Within 15 to 30 days after infection, however, 
increased numbers of CD44+ cells were detected in all 
organs examined. Dual-labelling and the use of two-color 
flow cytometry revealed that the number of CD4+ cells co­
expressing CD44 also increased in response to infection. 
This suggests that the recruited cells are increasing their 
expression of homing receptors and are therefore probably 
in some state of activation.
Cattle chronically infected with Mycobacterium 
paratuberculosis have a decreased capacity to produce IL-2
(6.17). Activation and proliferation of T lymphocytes is 
dependent upon the interaction of IL-2 with its cell
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membrane receptor (6.18). A similar defect in IL-2 
responsiveness is present in other mycobacterial infections 
as well. Cells from patients with atypical mycobacterial 
(MAI) infections produce very low levels of IL-2 production 
in response to PPD, but these cells may be stimulated to 
produce normal levels of IL-2 when treated with Con A, PHA, 
or PWM (6.18). Although there is decreased IL-2 
production, the expression and function of the IL-2 
receptor in cells from patients with MAI infections is not 
impaired (6.18). Mycobacterium leprae and its components 
have been shown to induce suppression of T cell 
proliferation in vitro in cells from both leprosy patients 
and uninfected controls (6.19). Cells isolated from the 
peripheral blood of BCG vaccinated patients have also been 
shown to inhibit the proliferation of other cells to BCG 
but not to other mitogens (6.20). Suppressor cells might 
therefore, act by inhibiting IL-2 production (6.18).
The results of this study demonstrate that detection 
of IL-2 receptor (CD25) expression by flow cytometry is 
decreased in a susceptible mouse strain (C57BL/6), whereas 
in the resistant strain, IL-2Rc expression increased in 
response to infection with Mycobacterium paratuberculosis. 
This suggests that resistant mice may develop a protective, 
Thl response, resulting in optimum macrophage activation 
and mycobacterial killing. Susceptible mice, on the other
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hand, fail to upregulate IL-2Rc expression and probably do 
not develop a protective immune response.
Although further proof is needed, this suggests that 
decreased IL-2Rc expression might be one of the factors 
involved in susceptibility to paratuberculosis. However, 
detection of an actual change in the expression of a cell 
surface receptor using monoclonal antibody techniques 
requires ruling out the possibility that some of the 
receptors are not simply masked by the presence of abundant 
quantities of its ligand, in this case interleukin 2 . 
Neither IL-2 or IL-4 was detected in cells infected with M. 
paratuberculosis in vitro. The failure to detect these 
cytokines could be due to a number of factors, such as too 
short of an incubation period, poor sensitivity of the 
assays employed, or inherent differences in the response of 
cells grown in vitro versus in vivo.
It is also plausible that the defect lies in the 
expression of the IL-2 receptor and not the production of 
IL-2 itself. It has been demonstrated in leprosy, for 
example, that the failure of T cells from lepromatous 
leprosy patients to respond to M. leprae was due to a 
defective IL-2 receptor expression mechanism (6.21).
If there is a bona fide decrease in the IL-2 receptor 
expression of susceptible animals, this may be secondary to 
a decreased production of IL-2. Additional studies are 
needed to test if the regulation of IL-2 or the expression
if the IL-2Rc are genuinely altered in mycobacterial 
infections. If IL-2 dysregulation is involved in the 
pathogenesis of mycobacterial disease, then perhaps 
modulation of the immune system through cytokine therapy 
could be therapeutically beneficial.
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CHAPTER 7. CONCLUSIONS 
Paratuberculosis is a chronic, insidious, intestinal 
disease of ruminants that results in annual losses of 
millions of dollars for the cattle industry (7.1). 
Comparatively few cattle actually die from the disease, as 
the vast majority of losses result from decreased 
production and weight gains which are often subtle and go 
undetected (7.1).
The lack of an accepted laboratory model for studying 
paratuberculosis should no longer hamper research into 
paratuberculosis. The results presented here indicate that 
C57BL/6 mice are a suitable model for studying the entry, 
pathogenesis, and the immunology of ruminant 
paratuberculosis. As in the ruminant, susceptible mice 
develop granulomatous lesions comprised of numerous 
macrophages and multinucleated giant cells in the 
mesenteric lymph nodes within 7 months postinoculation. 
These lesions contain viable acid-fast bacilli, and the 
disease is progressive, as demonstrated by the progression 
of the lesions and bacterial culture counts.
Comparative studies of the mycobacterial counts from 
chronically infected resistant and susceptible mice 
demonstrated that the former are markedly more resistant to 
Mycobacterium paratuberculosis♦ These data are compatible 
with the dogma that resistance to mycobacterial infections 
in mice is associated with the Beg gene.
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Comparative studies using susceptible and resistant 
mice may help determine what factor(s) make one individual 
susceptible to mycobacterial disease while another is 
resistant. Genetic mapping of cattle, in the hopes of 
identifying a bovine equivalent of the Beg gene of mice, 
might one day serve to eradicate paratuberculosis and 
several other cattle diseases by selective breeding.
Both resistant and susceptible mice developed non­
specific macrophage activation within 10 days after 
infection with Mycobacterium paratuberculosis. suggesting 
that the major T cell responses occur somewhere within this 
time period. No detectable differences were observed in 
listeria killing ability between the two strains of mice. 
This indicates that the mechanisms utilized by macrophages 
to control Listeria sp. may be different than those 
utilized to control mycobacteria. The listeria challenge 
assays were valuable in determining the peak timing of 
macrophage activation following M. paratuberculosis 
infection. The T cell response could then be analyzed 
during this time frame to determine what T cell subsets 
were important in activating these macrophages.
Studies of the murine T cell response to infection 
with M. paratuberculosis revealed that both control and 
infected resistant mice have a significantly larger 
complement of CD4+ cells as compared to the susceptible 
mice. Although only two strains of mice were employed in
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this study, this may prove to be a key factor in resistance 
to mycobacterial diseases. The increased proportion of 
CD4+ cells might be directly attributed to the Beg gene, 
possibly by directing the maturation of more CD4+ cells 
through the production of cytokines. Perhaps the key lies 
in the production of IL-12, a recently discovered cytokine 
that seems to direct the immune system towards the 
protective Thl type response (7.2).
Analysis of CD8+ and 7 S T cells demonstrated that 
these cell types both responded in high proportions to the 
mycobacterial infection in both resistant and susceptible 
strains of mice. The proportions of 75 T cells were 
actually higher in several organs of the susceptible 
strain, suggesting that if 7 S T cells do play a role in 
mycobacterial infections, it may be a detrimental one.
Significant differences in the expression of the 
interleukin-2 receptor were also detected in the peritoneal 
exudate cells responding to the infection. Expression of 
IL-2Rc by lymphocytes significantly increased in the 
resistant strain of mice, but decreased in the susceptible 
strain in response to infection with Mycobacterium 
paratuberculosis. This suggests that differences in IL-2 
regulation or function are also present between 
mycobacterial resistant and susceptible animals. This has 
been previously described in cattle infected with 
Mycobacterium paratuberculosis (7.4,7.5). Lymphocytes
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from chronically infected cattle have an impaired capacity 
to produce IL-2 when stimulated by appropriate antigens 
(7.4,7.5).
The results of these studies suggest that the major 
difference between the susceptible and resistant strain is 
the difference in the proportions of T cells subsets in the 
lymphoid organs. Helper T cells (CD4+) are associated with 
a mycobacterial resistant strain while increased numbers of 
y6 T cells are associated with the susceptible strain. The 
increase in yS T cells may therefore be directly involved 
in the pathogenesis or susceptibility to paratuberculosis. 
Previous reports using peripheral blood lymphocytes of 
cattle have suggested that yS T cells may actually be 
involved in the destruction of autologous CD4+ cells (7.3). 
According to this hypothesis, CD8+ cells are reportedly 
involved in down-regulating yS T cell cytotoxicity (7.3).
If this hypothesis is valid, the loss of CD4+ cells might 
be responsible for the unchecked bacterial proliferation in 
the latter stages of the disease (7.3). The results 
presented here, however, did not provide any evidence that 
CD4+ cells were being destroyed. Chronically infected mice 
still had proportions of CD4+ T cells equal to or higher 
than those of controls.
Other observations suggest that yS T cells may play a 
role in the pathogenesis of paratuberculosis. First, yS T 
cells are numerous in the epithelial layers of the ruminant
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gastrointestinal tract (7.6). Secondly, these cells have 
demonstrated reactivity to products of different 
mycobacterial species including M. leprae (7.7), M. bovis 
(7.8), and M. tuberculosis (7.8-9). Finally, the 
prominence of yS T cells in the circulation of young 
ruminants (7.6) coincides with the age of susceptibility of 
cattle to infection with Mycobacterium paratuberculosis.
There are several possible mechanisms by which the yS 
T cell could predispose the ruminant to developing 
paratuberculosis. One mechanism could be through the 
induction of alterations in the bacillus-infected 
macrophage. Perhaps Mycobacterium paratuberculosis 
organisms, once they are inside the cell, either stimulate 
a cell-surface change or halt the production of stress 
proteins that would otherwise trigger the yS T cell to 
destroy the infected cell. A second hypothesis is that 
stimulation of the 7 $ T cells leads to the secretion of 
certain cytokines that triggers the granulomatous lesions 
without invoking the protective CD4+ cell response. Others 
have suggested that yS T cells may be responsible for 
stimulating the formation of granulomatous lesions in 
certain leprosy lesions (7.7).
A more plausible theory is that tolerance to the 
invading bacillus is evoked through the yS T cell. 
Histologic observations of age-related changes in the 
ruminant ileal Peyer's patches have led to speculation that
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these patches may function as primary lymphoid organs in 
young animals (7.10). In addition, there is evidence that 
7 S T cells develop and mature in the intestines rather than 
the thymus (7.11). Since young ruminants have markedly 
increased numbers of yS T cells both in circulation and in 
the intestines, perhaps an immune-tolerance phenomenon 
occurs when large numbers of maturing yS T cells encounter 
large numbers of Mycobacterium paratuberculosis organisms. 
Distinction between self and non-self may fail to occur and 
the susceptible animal may allow bacterial proliferation 
without eliciting a protective immune response.
Future studies could be directed towards utilizing 
this information in therapeutic trials. Therapy directed 
against the yS T cell population given to neonatal calves 
during the age of susceptibility to the infection (under 
three months of age) may be considered. Although the 
functions of yS T cells are still not known, if they are 
somehow involved in down-regulating a protective immune 
response, then perhaps elimination of these cells in 
susceptible animals may prevent this immunosuppression. 
Further studies in laboratory animals are needed before 
this therapy can be employed.
Other potential therapies could be directed toward 
stimulating a protective immune response. Since resistance 
to mycobacterial disease is dependent upon specific types 
of CD4+ T cells, then modulation of these cell types or
their cytokines might be therapeutically useful. The CD4+ 
cells responsible for stimulating protective cell-mediated 
immunity are currently referred to as Thl (7.12). It has 
recently been shown that IL-12 can specifically promote the 
development and activation of this Thl response (7.13). 
Currently research is underway in other diseases to see if 
IL-12 therapy can modify and direct the immune response 
towards the protective Thl-type response (7.13). If these 
trials are successful, perhaps IL-12 therapy could benefit 
cattle with paratuberculosis as well.
At the present time, understanding of the immunology 
and pathogenesis of mycobacterial diseases is limited. 
Currently, there is much work being done in these areas. 
Hopefully, the secrets of the immune system and the 
mycobacteria will eventually be revealed, enabling us to 
understand, prevent, and/or treat these dreadful diseases 
that have plagued both humans and domestic animals 
throughout time.
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Table A.I. Mycobacterium paratuberculosis colony forming 
units (CFU) isolated from the spleens of infected mice at 
various postinoculation intervals.
C57BL/6 mice C3H/He mice
Days"
(p.i.)
nb M. para 
CFU0
SEd nb M. para
CFU®
SEd
3 3 2.7X106 1.6X105 3 2.9X106 3.2X105
10 7 3.3X107 1.3X107 3 7.4X105 1.0X105
15 7 2.4X107 5.4X103 ND --- ---
21 4 9.2X106 9. 3X10S ND --- _ —
30 9 1.5X107 6.4X106 ND --- ---
36 4 2.2X106 9.2X105 ND --- ---
79 4 3.9X106 8.1X105 ND --- ---
85 3 9.4X106 3.3X106 ND --- ---
194 ND --- --- 8 2.0X104 5.4X103
219 ND --- --- 9 6.9X103 1.0X103
226 3 4.3X107 4.0X107 4 5.3X103 1.7X103
269 3 5.3X106 1.2X106 4 1.8X104 9.3X102
a Number of days post-inoculation (p.i.) with
Mycobacterium paratuberculosis.
b Indicates the number of animals tested in each group,
c Mean number of colony forming units of Mycobacterium
paratuberculosis per spleen, 
d Standard error of the mean.
ND Not determined.
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Table B.l. Comparison of Listeria sp. colony forming units (CFU) obtained from the 
spleens of mice inoculated with Mycobacterium paratuberculosis (experiment no. 1).
24 hour Listeria assay* 48 hour Listeria assayb
* ep. l.
M.para
C3H/Hen mice C57BL/6 mice C3H/Hen mice C57BL/6 mice
cFtr1 ±SEe
. . . -
CFUd ±SEe CFU ±SE CFU ±SE
Control 1.7x10s 2. 4xl04 1.1x10s 3. 0x10s 5.9X106 2.9X106 4. lxlO7 1.7X107
4 day 4. 6xl04 9.9x10s ND ND 1.4x10s 2.2X104 ND ND
8 day 3.4xl03 8.8X102 1.3x10s 7.7X104 9.2x10s 3.7x10s 3.9x10s 1.2x10s
10 day ND ND 6. OxlO4 1.6X104 ND ND 4.6x10s 1.8X104
15 day 7.6x10s 1.9x10s 2.5X104 1.8X104 1.2x10s 3.4X104 4. lxlO4 1.9X104
22 day 6.3X104 2.9X104 8.4X104 2.9X104 8.6x10s 4.9x10s 1.2x10s 6.1x10s
30 day 1.3X104 3.6x10s 7. OxlO4 2.4X104 2.3x10s 4.4X104 1.2x10s 2.4x10s
3 6 day 5.7X104 1.3X104 1.2x10s 6.8X104 1.3X106 4.0x10s 1.1x10s 8.6x10s
79 day ND ND 1.7x10s 5.3X104 ND ND 5.0x10s 1.7x10s
85 day ND 
1 "«
ND 7. OxlO4 8.2x10s ND
1 . 1
ND
— ' 11 T .
1.9x10s 5.9x10s
a ________
b Data obtained from mice 48 hours after i.v. inoculation with Listeria sp. 
c Postinoculation (p.i.) interval after infection with 
Mvcobacterium paratuberculosis. 
d Colony forming units (CFU) of Listeria sp. per spleen, 
e Standard error of the mean of Listeria sp. CFU from the spleen.
Table B.2. Comparison of Listeria CFU from the spleen of mice infected with Mycobacterium
paratuberculosis. All counts were performed 24 hours after an i.v. infection with 4X105
viable Listeria sp. (experiment no. 2).
C3H/He mice C57BL/6 mice
P . I .
M .
para”
_ bn CFU
Listeri
ac
S E d P e nb CFU
Listeri
ac
S E d P e
Control 5 1.3X107 3 . 1X106 --- 4 1.9X106 7.0X105 ---
5 day 5 1.5X106 3.5X105 0.01 5 1.6X105 2.6X104 0.02
10 day 4 9 . 8X104 3.4X104 <0.01 4 8.3X104 2.2X104 0.04
15 day 4 6 . 1X104 1.4X104 <0.01 5 6.7X105 2.2X105 0.04
30 day 5 1.6X104 4.5X103 <0.01 4 1.3X105 2.9X104 0.04
a Postinoculation interval with Mycobacterium paratuberculosis. All mice 
including controls were inoculated with Listeria sp. 24 prior, 
b Number of animals tested in each group.
c Colony forming units (means) of Listeria isolated from the spleens,
d Standard error of the mean.
e P value indicating the significance of the difference between the CFU from the
infected groups and the uninfected control mice.
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Table C.l. Summary of the kinetics of the T cell response of the peritoneal exudate cells
of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n %CD3+b %CD4+c %CD8+C %y6+c
controls 6 14.7 ± 1.7 72.2 ± 3.8 13.8 ± 2.5 14.8 ± 2.4
3 days 3 34.9 ± 3.4* 50.7 ± 4.2* 19.7 ± 5.3 33.6 ± 5.1*
5 days 3 54.5 ± 5.3* 73.1 ± 4.6 1 0.6 ± 1.0 15.0 ± 4.4
10 days 3 70.2 ± 8.4* 35.6 ± 6.0* 25.5 ±10.3 34.3 ±17.4
15 days 3 53.8 ± 6.9* 34.8 ± 6.1* 10.7 ± 1.9 63.1 ±10.4*
30 days 3 67.0 ± 9.4* 48.5 ±15.2* 18.9 ± 3.3 30.3 ±18.2
5 months 3 39.5 ± 12.9* 26.5 ± 5.3* 7.3 ± 2.0 2.3 ± 1.9*
C57BL/6 mice 
(susceptible)
controls 6 24.5 ± 2.8 49.8 ± 2.4 16.5 ± 4.9 22.4 ± 3.2
3 days 3 59.2 ± 8.9* 36.6 ± 3.6* 32.4 ± 3.7 31.5 ± 5.7
5 days 3 43.7 ± 14.9 27.5 ± 7.6* 21.0 ± 3.6 62.7 ± 2.7*
10 days 3 62.0 ± 6 .6* 29.5 ± 4.6* 37.4 ± 0.5 36.3 ± 1.9*
15 days 3 72.0 ± 6 .6* 31.2 ± 4.2* 14.8 ± 4.8 65.8 ± 5.6*
30 days 3 77.8 ± 2.2* 51.0 ± 6.7 25.6 ± 4.8 24.9 ± 8.6
5 months 3 27.4 ± 6.9* 40.3 +12.9* 19.2 ± 4.8 11.5 ± 1.1*
a Postinoculation interval with Mycobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells ± standard error.
* Indicates a significant difference (P<0.05) from the uninfected controls.
Table C.2. Summary of the kinetics of the T cell response in the peritoneal exudate cells
of aged mice (of retired breeders) in response to infection with Mycobacterium
paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n %CD3+b %CD4+° %CD8+C %Y S+c
controls 3 8.2 ± 0.3 82.9 ± 4.9 16.3 ± 2.0 7.5 ± 2.8
5 days 3 32.1 ± 1.3* 34.1 ± 7.5* 12.5 ± 0.5 51.5 ± 6 .6*
10 days 3 51.1 ± 7.4* 39.3 ± 5.9* 17.4 ± 0.9 37.9 ± 7.0*
15 days 3 57.3 ± 5.4* 46.9 ± 2.0* 11.2 ± 1.5 42.3 ± 4.2*
30 days 3 42.2 ± 14.5* 49.8 ± 7.9* 25.4 ± 1.1* 23.5 ± 7.3
C57BL/6 mice 
(susceptible)
controls 3 25.6 ± 4.4 40.9 ± 5.6 45.7 ± 9.2 11.4 ± 5.6
5 days 3 60.1 ± 2.3* 20.5 ± 3.7* 12.6 ± 4.3* 52.7 ± 7.5*
10 days 3 68.7 ± 1.9* 24.0 ± 8.4 32.2 ± 8.2 43.8 ± 
16.3*
15 days 3 68.4 ± 2.9* 34.4 ± 3.4 15.6 ± 2.9* 52.1 ± 4.2*
30 days 3 79.1 ± 3.0* 41.3 ± 7.3 21.1 ± 4.1 36.1 ± 6 .8 *
a Postinoculation interval with Mycobacterium tuberculosis,
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells ± standard error.
* Indicates a significant difference (P<0.05) from the uninfected controls.
Table C.3. Summary of the kinetics of the T cell response in the spleens of C57BL/6 and
C3H/He mice to infected with Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n %CD3+b %CD4+c %CD8+c %75+c
controls 7 41.0 ± 3.1 71.1 ± 2.1 16.2 ± 2.2 10.8 ± 2.0
3 days 3 31.0 ± 1.9 74.0 ± 2.8 15.4 ± 0.8 12.8 ± 1.4
5 days 3 28.8 ± 2.2 77.9 ± 3.5 9.0 ± 1.2 25.0 ± 0.6
10 days 3 41.0 ± 8.7 63.8 ± 0.5 28.2 ± 1.4* 9.1 ± 0.6
15 days 3 25.3 ± 1.3* 52.8 ± 3.2* 15.2 ± 0.9 28.5 ± 3.4*
30 days 3 34.4 ± 2.4 73.9 ± 5.0 14.3 ± 1.9 16.3 ± 2.4
5 months 3 43.2 ± 2.7 66.8 ± 4.4 21.5 ± 1.9 3.5 ± 0.9
C57BL/6 mice 
(susceptible)
controls 6 51.1 ± 7.5 36.5 ± 3.0 54.8 ± 1.3 8.0 ± 0.6
3 days 3 64.8 ± 1.0 39.9 ± 0.4 43.3 ± 1.3* 11.6 ± 0.3
5 days 3 42.4 ± 1.8* 41.5 ± 3.1 47.4 ± 1.7* 13.7 ± 1.4
10 days 3 37.6 ± 0.8* 37.7 ± 1.8 51.5 ± 2.5 7.0 ± 0.5
15 days 3 72.0 ± 6.6 51.1 ± 4.3* 43.1 ± 3.8* 12.7 ± 3.3
30 days 3 47.4 ± 5.4 56.9 ± 3.5* 32.5 ± 3.0* 9.6 ± 3.2
5 months 3 54.8 ± 2.6 34.8 ± 2.9 45.0 ± 5.3 9.0 + 3.6
a Postinoculation interval with Mycobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.
Table C.4. Summary of the kinetics of the T cell response of the intestinal
intraepithelial lymphocytes of C57BL/6 and C3H/He mice infected with M. paratuberculosis.
C3H/He mice 
(resistant)
PI int.® n %CD3+b %CD4+c %CD8+c %7«+c
controls 4 83.1 ± 2.3 7.9 ± 0.6 92.7 ± 1.0 73.7 ± 2.6
3 days 3 74.4 ± 7.9 10.7 ± 4.8 97.6 ± 1.5 56.3 ± 11.1
5 days 3 80.3 ± 1.1 8.4 ± 1.0 95.3 ± 2.2 60.0 ±10.7*
10 days 3 85.5 ± 3.6 5.8 ± 2.4 88.1 ± 4.1 80.7 ± 5.8
15 days 3 75.1 ± 5.1 24.0 ± 9.7* 87.9 ± 2.6 81.1 ± 2.1
30 days 3 70.6 ± 2.7 22.2 ± 6.9* 72.2 ± 13.3* 73.6 ± 7.0
5 months 3 89.6 ± 0.3 29.7 ± 7.1 89.2 ± 1.8 18.3 ± 7.4
C57BL/6 mice 
(susceptible)
controls 3 82.0 ± 2.9 8.7 ± 1.8 85.8 ± 2.2 81.2 ± 3.5
3 days 3 89.6 ± 0.3 5.8 ± 0.1 87.4 ± 0.3 84.2 ± 1.3
5 days 3 85.8 ± 1.1 6.6 ± 1.1 90.5 ± 1.1 83.6 ± 1.2
10 days 3 89.7 ± 3.2 4.2 ± 1.1 93.2 ± 0.6 79.5 ± 12.0
15 days 3 80.9 ± 1.3 9.5 ± 2.2 94.0 ± 1.9 89.7 ± 3.0
30 days 3 84.7 ± 3.7 7.8 ± 1.9 87.6 ± 3.5 88.2 ± 1.2
5 months 3 93.7 ± 1.3 4.0 ± 1.5 89.4 ± 1.5 67.6 ± 3.4
a Postinoculation interval with Mvcobactermm paratuberculosis.
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.
Table C.5. Summary of the kinetics of the T cell response in the lamina propria of
C57BL/6 and C3H/He mice to infection with Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int." n %CD3+b %CD4+c %CD8+c %y5+c
controls 3 83.1 ± 2.3 64.8 ± 4.9 24.1 ± 1.1 40.7 ± 10.5
3 days 3 54.3 ± 2.3* 28.6 ± 2 .0* 64.6 ± 5.8* 39.1 ± 3.2
5 days 3 48.0 ± 1.6* 45.6 ± 2.3 47.2 ± 3.0* 37.1 ± 2.5
10 days 3 62.2 ± 4.7* 57.7 ± 4.6 42.0 ± 7.2 16.1 ± 3.0*
15 days 3 45.2 ± 2.8 53.4 ± 0.8 41.0 ± 1.1 41.5 ± 2.4
30 days 3 36.2 i 2.3 72.4 ± 7.1 19.5 ± 2.0 30.3 ± 3.1*
5 months 3 53.5 ± 7.8 58.1 ± 9.6 40.5 ± 7.4 5.1 ± 0.9
C57BL/6 mice 
(susceptible)
controls 6 40.5 ± 7.4 48.4 ± 2.4 32.5 ± 4.6 40.0 ± 4.6
3 days 3 47.0 ± 6.3 31.1 ± 5.0* 54.5 ± 6.0* 61.9 ± 5.1*
5 days 3 43.7 ± 7.0 36.4 ± 10.7* 47.7 ± 8.0* 39.5 ± 4.8
10 days 3 48.3 ± 7.5* 37.3 ± 4.3 36.9 ± 4.6 46.5 ± 10.3
15 days 3 62.8 ± 2 .8 * 35.8 ± 8.6 64.5 ± 15.7* 62.9 ± 9.9*
30 days 3 48.8 ± 2.2 65.9 ± 2.7* 18.2 ± 3.2 26.4 ± 3.3
5 months 3 51.3 ± 13.8 29.3 ± 4.2 47.5 ± 7.4 52.0 ± 13.7
a Postinoculation interval with Mycobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.
Table C.6 . Kinetics of the T cell response in the Peyer's Patches in response to 
intraperitoneal infection with Mycobacterium paratuberculosis. Each value represents 
pooled sample of at least 3 mice.
C3H/He mice 
(resistant)
P.I. int.8 %CD3+b %CD4+c %CD8+* %7«+c
0 46.2 59.7 27.3 18.8
3 44.2 79.4 12.7 8.0
5 39.0 83.8 20.8 10.0
10 70. 3 73.1 27.9 13.2
15 60.5 45.5 62.8 42.3
30 53.3 66.2 24.8 13.9
5m 61.5 67.1 22.5 3.6
C57BL/6 mice 0 44.9 44.9 40.4 39.3
(susceptible)
3 63 .9 41.9 40.5 31.8
5 48.5 53 .4 43.9 39.0
10 76.0 24.1 67.1 68.0
15 — — — —
30 70.6 42.6 52.7 29.3
5m 66.7 44.2 15.3 8.4
a Postinoculation interval with Mycobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD3.
c Expressed as a percentage of the total CD3+ cell population.
Table C.7. Summary of the kinetics of the T cell response in the mesenteric lymph nodes
of C57BL/6 and C3H/He mice to infected with Mvcobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n %CD3+b %CD4+c %CD8+° %yS+c
controls 3 93.1 ± 2.0 73.2 ± 0.9 26.0 ± 0.3 1.4 ± 0.1
3 days 3 96.8 ± 1.0 71.0 ± 0.6 29.0 ± 1.2 0.8 ± 0.3
5 days 3 79.2 ± 0.7 70.4 ± 3.1 23.9 ± 1.2 1.1 ± 0.2
10 days 3 88.2 ± 0.8 69.2 ± 1.3 26.5 ± 0.8 2.1 ± 0.2
15 days 3 96.4 ± 1.2 68.0 ± 0.8 28.9 ± 1.5 2.1 ± 0.1
30 days 3 92.1 ± 1.6 69.7 ± 1.2 28.7 ± 1.7 2.3 ± 0.2
C57BL/6 mice 
(susceptible)
controls 9 82.7 ± 2.3 42.3 ± 3.1 49.1 ± 1.7 5.0 ± 0.6
3 days 3 83.6 ± 4.6 34.5 ± 3.6* 61.6 ± 3.5* 9.4 ± 0.3*
5 days 3 60.5 ± 7.4 48.0 ± 2.7 44.4 ± 1.7 7.5 ± 0.8*
10 days 6 70.2 ± 5.2 38.2 ± 2.7 51.1 ± 2.4 7.3 ± 2.4
15 days 3 69.7 ± 3.4 49.1 ± 7.2* 37.5 ± 2.2* 9.0 ± 0.3*
30 days 3 82.4 ± 4.1 46.2 ± 2.9 47.8 ± 2.0 8.6 ± 0.5*
a Post inoculation interval with Mvcobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD3 ± standard error,
c Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.
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Table D.l. Cellular expression of activation markers CD44 and CD25 in the peritoneal
exudate of young C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n Total CD44+b DP CD4/CD44+' Total CD25+b DPCD4/CD25+0
controls 6 91.2 ± 2.5 53.1 ± 6.0 2.5 ± 1.3 8.8 ± 1.2
3 days 3 72.0 + 6.3* 63.1 ± 10.7 3.6 ± 2.1 4.5 ± 1.7*
5 days 3 47.0 ± 2.4 23.6 ± 0.9* 1.8 ± 0.1* 2.6 ± 0.2*
10 days 3 83.0 ± 6.0 65.7 ± 13.8 4.2 ± 1.2* 24.6 ± 21.5
15 days 3 90.1 ± 2.4 54.4 ± 2.5 9.5 ± 3.9* 11.7 ± 4.0
30 days 3 70.0 ± 12.0* 44.7 ± 12.0 2.6 ± 0.6 3.0 + 0.9*
5 months 3 98.4 ± 0.1* 92.3 ± 3.0* 0.6 ± 0.03 30.3 ± 4.1*
C57BL/6 mice 
(susceptible)
controls 6 97.2 ± 1.7 62.9 + 10.4 8.2 ± 1.0 32.0 ± 9.0
3 days 3 90.4 ± 0.9* 53.5 ± 7.1 5.1 ± 0.5* 4.1 ± 2.3*
5 days 3 94.8 ± 1.3 52.9 ± 21.1 4.2 ± 0.9* 13.8 ± 5.7
10 days 3 91.6 ± 1.1* 80.0 ± 9.9 3.6 ± 0.6* 6.1 ± 1.6*
15 days 3 87.6 ± 9.2 77.5 ± 11.8 4.4 ± 0.9* 6.2 ± 0.5*
30 days 3 89.6 + 1.7* 72.3 ± 6.6 2.5 ± 0.2* 4.2 ± 1.5*
5 months 3 99.0 ± 0.2 82.5 ± 9.8 4.5 ± 1.2* 14.0 ± 6.1
a Postinoculation interval with Mycobacterium paratuberculosis.
b Percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
c Percentage of the total CD4+ cells co-expressing CD44 or CD25 ± standard error.
Indicates that the value differs from the uninfected control mean 
with a P value of less than 0.1.
Table D.2. Summary of the cellular expression of activation markers CD44 and CD25 in the
peritoneal exudate of aged (retired breeders) C57BL/6 and C3H/He mice infected with
Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n Total CD44+b Total CD25+b
controls 3 87.7 ± 3.6 1.3 ± 0.7
5 days 3 29.6 ± 4.6* 2.2 ±0.1*
10 days 3 44.7 ± 11.9* 2.5 ± 0.6
15 days 3 56.2 ± 3.3* 3.4 + 0.6*
30 days 3 42.7 ± 4.9* 5.6 ± 0.4*
C57BL/6 mice 
(susceptible)
controls 6 85.7 ± 9.2 6.7 ± 0.6
5 days 3 70.5 ± 8.2 2.5 ± 1.0*
10 days 3 79.3 ± 1.6 2.4 ± 0.1*
15 days 3 87.2 ± 0.3 3.4 ± 0.4*
30 days 3 77.4 ± 9.2 3.8 ± 1.3
a Postinoculation interval with Mycobacterium paratuberculosis.
b Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error.
* Indicates that the value differs from the uninfected control mean
with a P value of less than 0.05.
Table D.3. Cellular expression of activation markers CD44 and CD25 in the spleens of
C57BL/6 and C3H/He mice infected with Mvcobacter ium paratuberculosis.
C3H/He mice 
(resistant)
PI int.“ n Total CD44+b DPCD4/CD44+c Total CD25+b DPCD4/CD25+c
controls 7 70.5 ± 3.3 26.1 ± 2.5 3.3 ± 0.7 6.1 ± 0.6
3 days 3 63.5 ± 2.8 27.7 ± 2.7 4.0 ± 0.1 9.6 ± 1.3*
5 days 3 60.8 ± 2.2* 30.8 ± 1.9 3.4 ± 0.2 8.4 ± 0.5*
10 days 3 53.2 ± 5.1 20.7 ± 1.3 2.5 + 0.3 5.3 ± 0.2
15 days 3 78.1 ± 3.4 37.6 ± 8.9 3.4 ± 0.7 7.7 ± 1.7
30 days 3 58.7 ± 4.4* 37.0 ± 3.2* 2.5 ± 0.3 7.9 ±1.8
5 months 3 71.0 ± 2.5 37.1 ± 0.1 2.3 ± 0.6 4.7 ± 1.2
C57BL/6 mice 
(susceptible)
controls 6 73.5 ± 1.0 35.9 + 1.0 2.1 ± 0.2 5.5 + 0.3
3 days 3 75.9 + 1.4 43.7 ± 1.0* 3.8 ± 0.3* 8.1 ± 0.6*
5 days 3 77.2 ± 2.2* 42.5 ± 1.0* 2.0 ± 0.2 6.8 ± 0.8*
10 days 3 74.7 ± 2.1 45.6 ± 3.5* 3.0 ± 0.3* 6.9 ± 0.8*
15 days 3 80.5 ± 5.7* 55.3 ± 7.4* 3.7 ± 0.3* 7.8 ± 1.5*
30 days 3 74.1 ± 2.0 73.5 ± 1.0 1.5 ± 0.2 4.5 ± 0.7
5 months 3 90.7 ± 1.3* 79.3 ± 8.6* 1.1 ± 0.3* 4.8 ± 2.6
a Postinoculation interval with Mvcobacterium paratuberculosis.
b Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
c Mean percentage of the total CD4+ cells co-expressing CD44 or CD25 (double
positive) ± standard error.
Indicates that the value differs from the uninfected control mean 
with a P value of less than 0.1.
Table D.4. Cellular expression of activation markers CD44 and CD25 amongst
intraepithelial lymphocytes (IEL) of C57BL/6 and C3H/He mice infected with Mycobacterium
paratuberculosis.
C3H/He mice 
(resistant)
PI int.'* n Total CD44+b DPCD4/CD44+c Total CD25+b DPCD4/CD25+'
controls 3 29.3 ± 2.7 63.2 ± 12.9 3.7 ± 1.4 10.8 ± 4.5
3 days 3 39.0 ± 5.3 73.4 ± 14.8 3.8 ± 0.9 9.7 ± 3.6
5 days 3 29.8 ± 1.9* 73.6 ± 5.3 1.9 + 0.6 7.0 ± 2.7
10 days 3 19.6 ± 7.3 78.5 ± 8.8 2.0 ± 0.5 23.2 ± 10.5
15 days 3 49.6 ± 4.8* 78.0 ± 9.0 3.9 ± 0.6 7.0 ± 2.6
30 days 3 64.3 ± 2.1* 80.5 ± 2.9 5.9 ± 1.0 22.1 ± 4.6
5 months 3 64.0 ± 5.0* 96.7 ± 1.6* 3.6 ± 0.5 1.7 ± 0.5
C57BL/6 mice 
(susceptible)
controls 6 28.4 + 1.5 47.1 + 1.5 4.6 ± 1.0 5.2 ± 1.3
3 days 3 28.7 ± 2.3 65.3 ± 6.4* 2.3 ± 0.4* 11.5 ± 2.8
5 days 3 23.2 ± 1.0* 69.6 ± 7.5* 1.5 ± 0.2 6.8 ± 2.2
10 days 3 32.0 ± 2.7 82.0 ± 11.2* 2.1 ± 1.0 7.6 ± 2.8
15 days 3 42.0 ± 2.8* 67.5 ± 6.7* 3.1 ± 0.9 12.0 ± 1.4*
30 days 3 31.0 ± 2.5 83.1 ± 4.3* 2.1 ± 0.4 9.6 ± 2.0
5 months 3 32.2 ± 8.0 90.7 ± 2.9* 0.9 ± 0.5* 6.3 i 1.4
a Post inoculation interval with Mycobacterium paratuberculosis.
b Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
c Mean percentage of the total CD4+ cells co-expressing CD44 or CD25 (double
positive) ± standard error.
Indicates that the value differs from the uninfected control mean 
with a P value of less than 0.1.
Table D.5. Cellular expression of activation markers CD44 and CD25 of lamina propria
lymphocytes (LPL) of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
C3H/He mice 
(resistant)
PI int.* n Total CD44+b DPCD4/CD44+c Total CD25+b DPCD4/CD25+c
controls 3 85.3 ± 2.9 61.9 ± 14.6 5.9 ± 0.7 5.9 ± 0.8
3 days 3 70.5 ± 9.5 70.5 ± 9.5 2.2 ± 0.2* 3.1 ± 0.7*
5 days 3 77.9 + 3.1 77.9 ± 3.1 4.7 ± 0.5 5.8 + 1.1
10 days 3 49.9 ± 21.7 49.9 ± 21.7 4.1 ± 1.3 3.3 ± 0.5*
15 days 3 97.2 ± 2.7* 97.2 + 2.7* 6.7 ± 3.9 3.2 ± 0.8*
30 days 3 88.9 ± 3.7 88.9 ± 3.7 5.3 + 2.3 6.9 ± 2.1
5 months 3 92.7 ± 3.6 92.7 ± 3.6 31.4 ± 28.5 1.8 + 0.7*
C57BL/6 mice 
(susceptible)
controls 6 67.6 ± 8.5 63.0 ± 9.7 7.5 ± 3.5 11.9 ± 5.7
3 days 3 70.9 ± 6.6 67.6 ± 2.0 9.6 ± 1.9 15.3 ± 3.9
5 days 3 62.5 ± 3.6 71.3 ± 3.2 3.6 ± 0.4 4.9 ± 0.2
10 days 3t 45.3 ± 5.9* 64.8f 3.8 + 1.8 ND
15 days 3 72.0 ± 6.1 91.1 ± 3.0* 4.6 ± 1.3 9.6 ± 4.6
30 days 3 88.7 ± 0.9 91.4 ± 1.4* 3.9 ± 0.7 5.2 ± 0.7
5 months 3 62.0 ± 20.5 50.8 ± 19.6 14.2 ± 1.7 45.3 ± 21.9
a Postmoculation interval with Mvcobacter ium paratuberculosis.
b Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
c Mean percentage of the total CD4+ cells co-expressing CD44 or CD25 (double
positive) ± standard error.
* Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1. 
f Samples were pooled and therefore only the mean was reported.
Table D.6. Summary of the cellular expression of activation markers CD44 and CD25 in the
mesenteric lymph nodes of C57BL/6 and C3H/He mice infected with Mycobacterium
paratuberculosis.
C3H/He mice 
(resistant)
PI int.® n Total CD44+b DPCD4/CD44+c Total CD25+b DPCD4/CD25+c
controls 2 12.9 ± 3.2 7.6 ± 1.0 2.2 ± 0.05 2.8 ± 0.0
3 days 3 14.0 ± 4.2 11.1 ± 3.1 2.4 ± 0.4 2.8 ±0.3
5 days 3 33.8 ± 7.4* 16.9 ± 3.8 2.4 ± 0.4 3.5 ± 0.6
10 days 3t 20.7t 10. Of 3. Of 4.4t
15 days 3t 19. 3t 4.3f 3.It 15.4t
30 days 3 39.3 ± 0.7* 36.5 + 0.5* 3.3 ± 0.6 3.8 ± 0.0
5 months 3 42.3 ± 0.4* 33.1 ± 2.4* 4.1 ± 0.2* 0.3 ± 0.1
C57BL/6 mice 
(susceptible)
controls 9 52.2 ± 1.9 34.2 ± 3.5 11.1 ± 4.6 7.1 ± 2.9
3 days 3 51.5 ± 1.5 40.2 ± 1.9 2.4 ± 0.3 5.1 ± 0.2
5 days 3 62.1 ± 2.5* 28.0 ± 2.2 2.7 + 0.7 5.0 ± 0.9
10 days 3 71.5 ± 3.5* 67.9 ± 3.3* 6.0 ± 1.0 3.1 ± 0.1
15 days 3t 72.3f 52. 6t 6.7t 10.9t
30 days 3 55.6 ± 4.6 45.5 ± 2.8* 2.1 ± 0.3 4.5 ± 0.6
5 months
. 1 1"K "■ .
3 ND ND ND ND
a Postinoculation interval with Mycobacterium paratuberculosis.
b Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
c Mean percentage of the total CD4+ cells co-expressing CD44 or CD25 (double
positive) ± standard error.
* Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1. 
t Samples were pooled and therefore only the mean is reported.
Table D.7. Summary of the cellular expression of activation markers CD44 and CD25 in the
Peyer's patches of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
Samples from each group were pooled.______________________  ________
C3H/He mice 
(resistant)
P.I. Int.* %CD44 %DP
CD4/44b
%CD25 %DP
CD4/25b
Control 47.6 18.8 4.7 5.4
3 days 69.2 53.3 2.2 2.8
5 days 67.8 46.2 2.9 3.4
10 days 58.4 42.0 3.0 3.3
15 days 66.0 60.1 4.1 6.2
30 days 75.1 55.5 5.1 9.3
5 months 71.3 48.5 5.9 4.4
C57BL/6 mice Control 71.0 56.0 5.0 5.4
(susceptible)
3 days 68.4 63.4 2.5 2.2
5 days 64.2 54.8 2.3 3.1
10 days 54.6 67.8 1.9 3.8
15 days ND ND ND ND
30 days 73.0 72.1 3.2 4.7
5 months 88.4 61.3 8.6 3.3
a Postmoculation interval with Mvcobactermm paratuberculosis.
b Percent double positive cells co-expressing CD4 and either CD44 or CD25.
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